A	O
novel	O
function	O
of	O
Stat1	B-protein
and	O
Stat3	B-protein
proteins	O
in	O
erythropoietin	B-protein
-induced	O
erythroid	O
differentiation	O
of	O
a	O
human	B-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

We	O
recently	O
determined	O
that	O
erythropoietin	B-protein
(	O
EPO	B-protein
)	O
activates	O
3	O
members	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
STAT	O
)	O
family	O
,	O
Stat1alpha	B-protein
,	O
Stat3	B-protein
,	O
and	O
Stat5	B-protein
,	O
in	O
the	O
human	B-cell_line
EPO-dependent	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
UT-7	B-cell_line
and	O
UT-7/EPO	B-cell_line
(	O
Kirito	O
et	O
al	O
,	O
J	O
Biol	O
Chem	O
272	O
:	O
16507	O
,	O
1997	O
)	O
.	O

In	O
addition	O
,	O
we	O
have	O
shown	O
that	O
Stat1alpha	B-protein
,	O
but	O
not	O
Stat3	B-protein
,	O
is	O
involved	O
in	O
EPO	B-protein
-induced	O
cellular	O
proliferation	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
roles	O
of	O
Stat1alpha	B-protein
and	O
Stat3	B-protein
in	O
EPO	B-protein
-induced	O
erythroid	O
differentiation	O
.	O

UT-7/GM	B-cell_line
was	O
used	O
as	O
a	O
model	O
system	O
,	O
because	O
this	O
cell	O
line	O
can	O
differentiate	O
into	O
erythroid-lineage	B-cell_type
cells	I-cell_type
with	O
EPO	B-protein
treatment	O
(	O
Komatsu	O
et	O
al	O
,	O
Blood	O
89	O
:	O
4021	O
,	O
1997	O
)	O
.	O

We	O
found	O
that	O
EPO	B-protein
did	O
not	O
activate	O
Stat1alpha	B-protein
or	O
Stat3	B-protein
in	O
UT-7/GM	B-cell_line
cells	I-cell_line
.	O

Transfection	O
experiments	O
showed	O
that	O
both	O
Stat1alpha	B-protein
and	O
Stat3	B-protein
inhibited	O
the	O
induction	O
by	O
EPO	B-protein
of	O
gamma-globin	B-RNA
and	I-RNA
erythroid-specific	I-RNA
5-aminolevulinate	I-RNA
synthetase	I-RNA
transcripts	I-RNA
,	O
resulting	O
in	O
a	O
reduction	O
of	O
the	O
percentage	O
of	O
hemoglobin-positive	B-cell_type
cells	I-cell_type
.	O

Dominant	O
negative	O
forms	O
of	O
Stat1alpha	B-protein
or	O
Stat3	B-protein
promoted	O
the	O
EPO	B-protein
-induced	O
erythroid	O
differentiation	O
of	O
UT-7/GM	B-cell_line
cells	I-cell_line
,	O
even	O
in	O
the	O
presence	O
of	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
,	O
although	O
this	O
cytokine	O
never	O
induced	O
erythroid	O
differentiation	O
of	O
the	O
parent	B-cell_line
UT-7/GM	I-cell_line
cells	I-cell_line
with	O
or	O
without	O
EPO	B-protein
.	O

A	O
cell	O
cycle	O
analysis	O
showed	O
that	O
the	O
constitutive	O
activation	O
of	O
Stat1alpha	B-protein
,	O
but	O
not	O
Stat3	B-protein
,	O
shortened	O
the	O
period	O
of	O
G0/G1	O
prolongation	O
caused	O
by	O
EPO	B-protein
stimulation	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
Stat1alpha	B-protein
and	O
Stat3	B-protein
act	O
as	O
negative	O
regulators	O
in	O
EPO	B-protein
-induced	O
erythroid	O
differentiation	O
.	O

Specifically	O
,	O
Stat1alpha	B-protein
may	O
activate	O
a	O
cell	B-DNA
cycle-associated	I-DNA
gene	I-DNA
(	O
s	O
)	O
,	O
leading	O
to	O
the	O
entry	O
of	O
cells	O
into	O
the	O
cell	O
cycle	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A	NULL
Novel	NULL
Function	NULL
of	NULL
Statla	NULL
and	NULL
Stat3	NULL
Proteins	NULL
in	NULL
Erythropoietin-Induced	NULL
Erythroid	NULL
Differentiation	NULL
of	NULL
a	NULL
Human	NULL
Leukemia	NULL
Cell	NULL
Line	NULL
By	NULL
Keita	NULL
Kirito	NULL
,	NULL
Mie	NULL
Uchida	NULL
,	NULL
Masaaki	NULL
Takatoku	NULL
,	NULL
Koichi	NULL
Nakajima	NULL
,	NULL
Toshio	NULL
Hirano	NULL
,	NULL
Yasusada	NULL
Miura	NULL
,	NULL
and	NULL
Norio	NULL
Komatsu	NULL
We	NULL
recently	NULL
determined	NULL
that	NULL
erythropoietin	NULL
(	NULL
EPO	NULL
)	NULL
activates	NULL
3	NULL
members	NULL
of	NULL
the	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
family	NULL
,	NULL
Stati	NULL
«	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
Stat5	NULL
,	NULL
in	NULL
the	NULL
human	NULL
EPO-dependent	NULL
cell	NULL
lines	NULL
,	NULL
UT-7	NULL
and	NULL
UT-7/	NULL
EPO	NULL
(	NULL
Kirito	NULL
et	NULL
al	NULL
,	NULL
J	NULL
Biol	NULL
Chem	NULL
272:16507	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
show	NULL
n	NULL
that	NULL
Statia	NULL
«	NULL
,	NULL
but	NULL
not	NULL
Stat3	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
EPO-induced	NULL
cellular	NULL
proliferation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
roles	NULL
of	NULL
Statice	NULL
and	NULL
Stat3	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

UT-7/	NULL
GM	NULL
was	NULL
used	NULL
as	NULL
a	NULL
model	NULL
system	NULL
,	NULL
because	NULL
this	NULL
cell	NULL
line	NULL
can	NULL
differentiate	NULL
into	NULL
erythroid-lineage	NULL
cells	NULL
w	NULL
ith	NULL
EPO	NULL
treatment	NULL
(	NULL
Komatsu	NULL
et	NULL
al	NULL
,	NULL
Blood	NULL
89:4021	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
EPO	NULL
did	NULL
not	NULL
activate	NULL
Stati	NULL
«	NULL
or	NULL
Stat3	NULL
in	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

Transfection	NULL
experiments	NULL
showed	NULL
that	NULL
both	NULL
Stati	NULL
«	NULL
and	NULL
Stat3	NULL
inhibited	NULL
the	NULL
induction	NULL
by	NULL
EPO	NULL
of	NULL
y-globin	NULL
and	NULL
erythroid-specific	NULL
5-aminolevulinate	NULL
synthetase	NULL
transcripts	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
reduc-	NULL
RYTHROPOIETIN	NULL
(	NULL
EPO	NULL
)	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
binding	NULL
of	NULL
EPO	NULL
to	NULL
its	NULL
specific	NULL
receptor	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
several	NULL
proteins	NULL
,	NULL
including	NULL
Janus	NULL
kinase	NULL
2	NULL
(	NULL
JAK2	NULL
)	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
5	NULL
(	NULL
Stat5	NULL
)	NULL
,	NULL
``	NULL
~	NULL
mitogen-associated	NULL
protein	NULL
kinases	NULL
,	NULL
©	NULL
and	NULL
phospholipase	NULL
C-y1	NULL
.	NULL
``	NULL

We	NULL
recently	NULL
demonstrated	NULL
that	NULL
EPO	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
Statlae	NULL
and	NULL
Stat3	NULL
in	NULL
the	NULL
EPO-dependent	NULL
cell	NULL
lines	NULL
UT-7	NULL
,	NULL
its	NULL
subline	NULL
UT-7/EPO	NULL
,	NULL
and	NULL
F36E	NULL
.	NULL

*	NULL
``	NULL
By	NULL
contrast	NULL
,	NULL
EPO	NULL
did	NULL
not	NULL
activate	NULL
Statlo	NULL
and	NULL
Stat3	NULL
in	NULL
UT-7/GM	NULL
,	NULL
another	NULL
subline	NULL
of	NULL
UT-7	NULL
,	NULL
or	NULL
in	NULL
TF-1	NULL
cells	NULL
,	NULL
which	NULL
grow	NULL
only	NULL
minimally	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EPO	NULL
.	NULL
'	NULL

>	NULL
*5	NULL
Transfection	NULL
experiments	NULL
with	NULL
Statloe	NULL
and/or	NULL
Stat3	NULL
showed	NULL
that	NULL
the	NULL
overexpression	NULL
of	NULL
Statl	NULL
«	NULL
,	NULL
but	NULL
not	NULL
Stat3	NULL
,	NULL
promoted	NULL
the	NULL
EPO-induced	NULL
proliferation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
introduction	NULL
of	NULL
EPO	NULL
receptor	NULL
(	NULL
EPOR	NULL
)	NULL
cDNA	NULL
into	NULL
UT-7/GM	NULL
cells	NULL
restored	NULL
not	NULL
only	NULL
the	NULL
growth	NULL
response	NULL
to	NULL
EPO	NULL
,	NULL
but	NULL
also	NULL
the	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
.	NULL
``	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
Statla	NULL
is	NULL
at	NULL
least	NULL
partly	NULL
involved	NULL
in	NULL
EPO-induced	NULL
cell	NULL
growth	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
roles	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
,	NULL
because	NULL
STAT	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Tochigi	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Oncology	NULL
,	NULL
Biomedical	NULL
Research	NULL
Center	NULL
,	NULL
Osaka	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
.	NULL

Submitted	NULL
December	NULL
30	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
March	NULL
18	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
Grants-in-Aid	NULL
for	NULL
Cancer	NULL
Research	NULL
and	NULL
Scientific	NULL
Research	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Yamanouchi	NULL
Foundation	NULL
for	NULL
Research	NULL
on	NULL
Metabolic	NULL
Disorders	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Norio	NULL
Komaisu	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
Minami-kawachi-machi	NULL
,	NULL
Tochigi-ken	NULL
329-04	NULL
,	NULL
Japan	NULL
;	NULL
e-mail	NULL
:	NULL
nkomaisu	NULL
@	NULL
ms.jichi.ac.jp	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9202-0017	NULL
$	NULL
3.00/0	NULL
462	NULL
tion	NULL
of	NULL
the	NULL
percentage	NULL
of	NULL
hemoglobin-positive	NULL
cells	NULL
.	NULL

Dominant	NULL
negative	NULL
forms	NULL
of	NULL
Statie	NULL
or	NULL
Stat3	NULL
promoted	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
although	NULL
this	NULL
cytokine	NULL
never	NULL
induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
the	NULL
parent	NULL
UT-7/	NULL
GM	NULL
cells	NULL
w	NULL
ith	NULL
or	NULL
without	NULL
EPO	NULL
.	NULL

A	NULL
cell	NULL
cycle	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Stati	NULL
«	NULL
,	NULL
but	NULL
not	NULL
Stat3	NULL
,	NULL
shortened	NULL
the	NULL
period	NULL
of	NULL
G0/G1	NULL
prolongation	NULL
caused	NULL
by	NULL
EPO	NULL
stimulation	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
Statice	NULL
and	NULL
Stat3	NULL
act	NULL
as	NULL
negative	NULL
regulators	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Specifically	NULL
,	NULL
Static	NULL
may	NULL
activate	NULL
a	NULL
cell	NULL
cycle-associated	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
entry	NULL
of	NULL
cells	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

proteins	NULL
appear	NULL
to	NULL
play	NULL
some	NULL
role	NULL
in	NULL
hematopoiesis	NULL
.	NULL

'*	NULL
'	NULL
``	NULL
For	NULL
example	NULL
,	NULL
Stat3	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
-induced	NULL
macrophage	NULL
differentiation	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
-induced	NULL
granulocytic	NULL
differentia-tion	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
the	NULL
concept	NULL
is	NULL
controversial	NULL
at	NULL
present	NULL
,	NULL
Stat5	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

!	NULL
``	NULL

Thus	NULL
,	NULL
STAT	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Because	NULL
UT-7/GM	NULL
and	NULL
TP-1	NULL
cells	NULL
can	NULL
differentiate	NULL
into	NULL
erythroid	NULL
cells	NULL
after	NULL
exposure	NULL
to	NULL
EPO	NULL
,	NULL
'*	NULL
``	NULL
5	NULL
the	NULL
loss	NULL
of	NULL
activation	NULL
of	NULL
Statl	NULL
«	NULL
and	NULL
Stat3	NULL
by	NULL
EPO	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
used	NULL
UT-7/GM	NULL
transfectant	NULL
cells	NULL
exogenously	NULL
expressing	NULL
Statloe	NULL
and/or	NULL
Stat3	NULL
proteins	NULL
``	NULL
and	NULL
examined	NULL
the	NULL
biological	NULL
functions	NULL
of	NULL
these	NULL
Stat	NULL
proteins	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
both	NULL
Statle	NULL
and	NULL
Stat3	NULL
proteins	NULL
inhibit	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

The	NULL
UT-7	NULL
cell	NULL
line	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
megakaryoblastic	NULL
leukemia	NULL
.	NULL
``	NULL

''	NULL
UT-7	NULL
and	NULL
UT-7/GM	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
liquid	NULL
culture	NULL
with	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
(	NULL
IMDM	NULL
;	NULL
GIBCO	NULL
Laboratories	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
and	NULL
1	NULL
ng/mL	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
.	NULL

Hematopoietic	NULL
growth	NULL
factors	NULL
and	NULL
reagents	NULL
.	NULL

-	NULL
Recombinant	NULL
human	NULL
EPO	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
the	NULL
Life	NULL
Science	NULL
Research	NULL
Institute	NULL
of	NULL
the	NULL
Snow	NULL
Brand	NULL
Milk	NULL
Company	NULL
(	NULL
Tochigi	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
GM-CSF	NULL
was	NULL
provided	NULL
by	NULL
Sumitomo	NULL
Pharmaceutical	NULL
Co	NULL
(	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Neomycin	NULL
(	NULL
G418	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
GIBCO	NULL
BRL	NULL
Life	NULL
Technologies	NULL
(	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Human	NULL
erythroid-specific	NULL
5-aminolevulinate	NULL
synthetase	NULL
(	NULL
ALAS-E	NULL
)	NULL
cDNA	NULL
was	NULL
provided	NULL
by	NULL
Dr	NULL
M.	NULL
Yamamoto	NULL
(	NULL
Tsukuba	NULL
University	NULL
,	NULL
Tsukuba	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Human	NULL
y-globin	NULL
cDNA	NULL
and	NULL
a	NULL
human	NULL
ribosomal	NULL
DNA	NULL
probe	NULL
were	NULL
provided	NULL
by	NULL
the	NULL
Japanese	NULL
Cancer	NULL
Research	NULL
Resources	NULL
Bank	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
human	NULL
EPOR	NULL
cDNA	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
H.	NULL
Nakauchi	NULL
(	NULL
Tsukuba	NULL
University	NULL
,	NULL
Tsukuba	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Dianisidine	NULL
staining	NULL
.	NULL

Hemoglobin	NULL
concentrations	NULL
were	NULL
examined	NULL
by	NULL
incubating	NULL
cells	NULL
in	NULL
serum-free	NULL
IMDM	NULL
medium	NULL
containing	NULL
0.2	NULL
%	NULL
3,3'-dimethoxybenzidine	NULL
,	NULL
fast	NULL
blue	NULL
B	NULL
(	NULL
dianisidine	NULL
;	NULL
Sigma	NULL
Chemicals	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
0.3	NULL
%	NULL
acetic	NULL
acid	NULL
,	NULL
and	NULL
0.3	NULL
%	NULL
H	NULL
;	NULL
O	NULL
;	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
RT	NULL
)	NULL
.	NULL

*	NULL
!	NULL

Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
2	NULL
(	NULL
July	NULL
15	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
462-471	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

STAT	NULL
PROTEINS	NULL
AND	NULL
ERYTHROID	NULL
DIFFERENTIATION	NULL
Preparation	NULL
of	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
.	NULL

-	NULL
After	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
2	NULL
mmol/L	NULL
NasVO,4	NULL
,	NULL
resuspended	NULL
in	NULL
a	NULL
hypotonic	NULL
buffer	NULL
(	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
1	NULL
mmol/L	NULL
MgC	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mmol/L	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
1	NULL
mmol/L	NULL
phenylmethyl-sulphonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
15	NULL
ug/mL	NULL
aprotinin	NULL
,	NULL
3	NULL
ug/mL	NULL
leupeptin	NULL
,	NULL
3	NULL
ug/mL	NULL
pepstatin	NULL
,	NULL
and	NULL
2	NULL
mmol/L	NULL
Na	NULL
;	NULL
VO4	NULL
,	NULL
)	NULL
with	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
and	NULL
then	NULL
homogenized	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
1,000	NULL
;	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
separated	NULL
from	NULL
the	NULL
nuclear	NULL
pellet	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
14,0005	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
debris	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
collected	NULL
as	NULL
cytoplasmic	NULL
extracts	NULL
.	NULL

The	NULL
nuclear	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
hypotonic	NULL
buffer	NULL
with	NULL
300	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
(	NULL
14,000g	NULL
for	NULL
20	NULL
minutes	NULL
)	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
collected	NULL
as	NULL
nuclear	NULL
extracts	NULL
.	NULL

Electromobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Nuclear	NULL
or	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
4°C	NULL
in	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
75	NULL
mmol/L	NULL
KCI	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1.5	NULL
ug	NULL
of	NULL
poly	NULL
dIC/dAT	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
and	NULL
4	NULL
%	NULL
Ficoll	NULL
type	NULL
400	NULL
,	NULL
with	NULL
2	NULL
ng	NULL
of	NULL
a	NULL
32	NULL
P-labeled	NULL
oligonucleotide	NULL
.	NULL

Samples	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
5	NULL
%	NULL
nondenatur-ating	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
run	NULL
for	NULL
1.5	NULL
hours	NULL
at	NULL
150	NULL
V	NULL
,	NULL
vacuum-dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

For	NULL
the	NULL
supershift	NULL
study	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
antibodies	NULL
at	NULL
RT	NULL
for	NULL
10	NULL
minutes	NULL
before	NULL
the	NULL
above	NULL
reaction	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
double-stranded	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
sis-inducible	NULL
element	NULL
(	NULL
SIE	NULL
;	NULL
upper	NULL
strand	NULL
,	NULL
5'-GTCGACATTTC-CCGTAAATC-3	NULL
'	NULL
)	NULL
``	NULL
and	NULL
the	NULL
B-casein	NULL
promoter	NULL
region	NULL
(	NULL
B-CAP	NULL
;	NULL
upper	NULL
strand	NULL
,	NULL
5-AGATTTCTAGGAATTCAAATC-3	NULL
'	NULL
)	NULL
.	NULL
``	NULL

''	NULL
In	NULL
the	NULL
study	NULL
of	NULL
com-petition	NULL
,	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
150	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
probe	NULL
.	NULL

Generation	NULL
of	NULL
stable	NULL
transfectants	NULL
.	NULL

-	NULL
UT-7/GM	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
mammalian	NULL
expression	NULL
vector	NULL
(	NULL
pCAGGSneo	NULL
)	NULL
alone	NULL
or	NULL
pCAGGSneo	NULL
containing	NULL
human	NULL
Statle	NULL
cDNA	NULL
,	NULL
murine	NULL
Stat3	NULL
cDNA	NULL
,	NULL
'*	NULL
or	NULL
human	NULL
EPOR	NULL
cDNA	NULL
by	NULL
conventional	NULL
electroporation	NULL
(	NULL
1,000	NULL
V	NULL
,	NULL
25	NULL
uFD	NULL
)	NULL
.	NULL

We	NULL
selected	NULL
3	NULL
independent	NULL
clones	NULL
resistant	NULL
to	NULL
neomycin	NULL
(	NULL
0.8	NULL
mg/mL	NULL
)	NULL
.	NULL

To	NULL
make	NULL
UT-7/GM	NULL
cells	NULL
that	NULL
overexpressed	NULL
both	NULL
Statle	NULL
and	NULL
Stat3	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
pCAGGS-BSD	NULL
vector	NULL
containing	NULL
a	NULL
blasticidin-resistant	NULL
gene	NULL
.	NULL
``	NULL

The	NULL
tyrosine	NULL
residues	NULL
at	NULL
701	NULL
of	NULL
Statl	NULL
and	NULL
at	NULL
705	NULL
of	NULL
Stat3	NULL
were	NULL
replaced	NULL
with	NULL
phenylalanine	NULL
to	NULL
make	NULL
StatlF	NULL
and	NULL
Stat3F	NULL
,	NULL
respectively	NULL
.	NULL
``	NULL

StatlF	NULL
or	NULL
Stat3F	NULL
cDNA	NULL
also	NULL
was	NULL
inserted	NULL
into	NULL
pCAGGS	NULL
vector	NULL
and	NULL
introduced	NULL
into	NULL
UT-7/GM	NULL
cells	NULL
under	NULL
the	NULL
above	NULL
conditions	NULL
.	NULL

Luciferase	NULL
assay	NULL
.	NULL

-	NULL
UT-7/GM	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
DNA	NULL
by	NULL
the	NULL
lipofectin	NULL
method	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Pro-mega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Typically	NULL
,	NULL
1.0	NULL
ug	NULL
of	NULL
one	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
containing	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
pSV-B-galactosidase	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
LacZ	NULL
gene	NULL
encoding	NULL
B-galactosidase	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
were	NULL
used	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
the	NULL
pCAGGS-Neo	NULL
expression	NULL
vector	NULL
system	NULL
with	NULL
a	NULL
cDNA	NULL
encoding	NULL
HA-Stat1	NULL
,	NULL
HA-Stat3	NULL
,	NULL
or	NULL
their	NULL
derivatives	NULL
were	NULL
cotransfected	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
stimulated	NULL
with	NULL
10	NULL
ng/mL	NULL
of	NULL
GM-CSF	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
collected	NULL
in	NULL
100	NULL
uL	NULL
lysis	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
the	NULL
assay	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
reporter	NULL
genes	NULL
contain	NULL
4	NULL
copies	NULL
of	NULL
the	NULL
acute-phase	NULL
response	NULL
element	NULL
(	NULL
APRE	NULL
)	NULL
,	NULL
which	NULL
is	NULL
transactivated	NULL
by	NULL
Statle	NULL
.	NULL

and	NULL
Stat3	NULL
,	NULL
in	NULL
front	NULL
of	NULL
the	NULL
minimal	NULL
junB	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
AXAPREluc	NULL
)	NULL
.	NULL
'	NULL

5	NULL
Colorimetric	NULL
MIT	NULL
assay	NULL
for	NULL
cell	NULL
proliferation	NULL
.	NULL

Cell	NULL
growth	NULL
was	NULL
also	NULL
examined	NULL
by	NULL
a	NULL
colorimetric	NULL
assay	NULL
according	NULL
to	NULL
Mosmann	NULL
,	NULL
*	NULL
``	NULL
with	NULL
some	NULL
modification	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10	NULL
%	NULL
/0.1	NULL
mL	NULL
in	NULL
96-well	NULL
plates	NULL
in	NULL
IMDM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
GM-CSF	NULL
or	NULL
EPO	NULL
.	NULL

After	NULL
72	NULL
hours	NULL
of	NULL
culture	NULL
at	NULL
37°C	NULL
,	NULL
20	NULL
uL	NULL
of	NULL
sterilized	NULL
5	NULL
mg/mL	NULL
MTT	NULL
[	NULL
3-	NULL
(	NULL
4.5-dimethylthiazol-2-y1	NULL
)	NULL
-2.5-diphenyltetrazolium	NULL
bromide	NULL
;	NULL
Sigma	NULL
]	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
.	NULL

After	NULL
2	NULL
hours	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
100	NULL
uL	NULL
of	NULL
10	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
to	NULL
dissolve	NULL
the	NULL
dark-blue	NULL
crystal	NULL
product	NULL
.	NULL

The	NULL
optical	NULL
density	NULL
(	NULL
OD	NULL
)	NULL
was	NULL
measured	NULL
at	NULL
463	NULL
a	NULL
wavelength	NULL
of	NULL
595	NULL
nm	NULL
using	NULL
a	NULL
microplate	NULL
reader	NULL
(	NULL
model	NULL
3550	NULL
;	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
Northern	NULL
blotting	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Chomezynski	NULL
and	NULL
Sacchi	NULL
.	NULL
``	NULL

''	NULL
RNA	NULL
was	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
agarose	NULL
formaldehyde	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
Zeta-probe	NULL
;	NULL
Bio-Rad	NULL
)	NULL
in	NULL
10	NULL
%	NULL
standard	NULL
sodium	NULL
citrate	NULL
(	NULL
SSC	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
human	NULL
cDNA	NULL
fragments	NULL
for	NULL
ALAS-E	NULL
or	NULL
y-globin	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
labeled	NULL
with	NULL
°P-	NULL
@	NULL
«	NULL
CTP	NULL
by	NULL
random-priming	NULL
.	NULL

After	NULL
an	NULL
overnight	NULL
incubation	NULL
at	NULL
43°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
blots	NULL
were	NULL
washed	NULL
3	NULL
times	NULL
with	NULL
2X	NULL
SSC	NULL
,	NULL
0.5	NULL
%	NULL
SSC	NULL
,	NULL
or	NULL
0.1	NULL
%	NULL
SSC	NULL
containing	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
minutes	NULL
each	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
autoradiographed	NULL
using	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
at	NULL
-70°C	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
.	NULL

-	NULL
A	NULL
cell	NULL
cycle	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
staining	NULL
DNA	NULL
with	NULL
propidium	NULL
iodide	NULL
in	NULL
preparation	NULL
for	NULL
flow	NULL
cytometry	NULL
with	NULL
the	NULL
FACScan/ModFit	NULL
LT	NULL
system	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RESULTS	NULL
Correlation	NULL
between	NULL
the	NULL
GM-CSF-induced	NULL
activation	NULL
of	NULL
Statla	NULL
and	NULL
Stat3	NULL
and	NULL
the	NULL
GM-CSF-induced	NULL
inhibition	NULL
of	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
Statl	NULL
«	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
Stat5	NULL
were	NULL
commonly	NULL
activated	NULL
by	NULL
EPO	NULL
in	NULL
UT-7	NULL
cells	NULL
and	NULL
that	NULL
EPO	NULL
induced	NULL
the	NULL
activation	NULL
of	NULL
Stat5	NULL
but	NULL
not	NULL
of	NULL
Statl	NULL
«	NULL
or	NULL
Stat3	NULL
in	NULL
UT-7/GM	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
UT-7/GM	NULL
cells	NULL
can	NULL
differentiate	NULL
along	NULL
the	NULL
erythroid	NULL
lineage	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EPO	NULL
and	NULL
that	NULL
GM-CSF	NULL
inhibited	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL
``	NULL

Collectively	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
may	NULL
be	NULL
closely	NULL
involved	NULL
in	NULL
the	NULL
inhibition	NULL
by	NULL
GM-CSF	NULL
of	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

To	NULL
test	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
SIE-binding	NULL
complexes	NULL
formed	NULL
after	NULL
stimulation	NULL
with	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
plus	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
.	NULL

About	NULL
80	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
became	NULL
dianisidine-positive	NULL
after	NULL
7	NULL
days	NULL
of	NULL
exposure	NULL
to	NULL
EPO	NULL
alone	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
GM-CSF	NULL
strongly	NULL
reduced	NULL
the	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
high-dose	NULL
EPO	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

GM-CSF	NULL
activated	NULL
Statlo	NULL
and	NULL
Stat3	NULL
at	NULL
10	NULL
ng/mL	NULL
,	NULL
at	NULL
which	NULL
concentration	NULL
the	NULL
dianisidine-positive	NULL
cells	NULL
completely	NULL
disappeared	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Stats	NULL
was	NULL
commonly	NULL
activated	NULL
by	NULL
GM-CSF	NULL
and	NULL
EPO	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
positive	NULL
correlation	NULL
between	NULL
the	NULL
GM-CSF-induced	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
and	NULL
the	NULL
GM-CSF-induced	NULL
inhibition	NULL
of	NULL
EPO-dependent	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Overexpression	NULL
of	NULL
Statla	NULL
or	NULL
Stat3	NULL
proteins	NULL
suppressed	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
inhibits	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
,	NULL
we	NULL
used	NULL
Statla-	NULL
or	NULL
Stat3-transfected	NULL
UT-7/GM	NULL
cells	NULL
that	NULL
we	NULL
generated	NULL
previously	NULL
.	NULL
``	NULL

We	NULL
confirmed	NULL
that	NULL
Statle	NULL
and	NULL
Stat3	NULL
proteins	NULL
are	NULL
overexpressed	NULL
and	NULL
constitutively	NULL
activated	NULL
in	NULL
each	NULL
type	NULL
of	NULL
transfectant	NULL
cells	NULL
(	NULL
Kirito	NULL
et	NULL
al	NULL
``	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

UT-7/GM	NULL
clones	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

These	NULL
transfectant	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
10	NULL
U/mL	NULL
EPO	NULL
for	NULL
7	NULL
days	NULL
and	NULL
then	NULL
harvested	NULL
for	NULL
dianisidine	NULL
staining	NULL
.	NULL

Dianisidine-positive	NULL
cells	NULL
were	NULL
not	NULL
observed	NULL
before	NULL
exposure	NULL
to	NULL
EPO	NULL
,	NULL
but	NULL
70	NULL
%	NULL
to	NULL
80	NULL
%	NULL
of	NULL
the	NULL
control	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
dianisidine	NULL
after	NULL
7	NULL
days	NULL
of	NULL
exposure	NULL
to	NULL
EPO	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
decreased	NULL
to	NULL
40	NULL
%	NULL
to	NULL
45	NULL
%	NULL
in	NULL
the	NULL
Statlee	NULL
or	NULL
Stat3	NULL
transfectant	NULL
clones	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

We	NULL
also	NULL
evaluated	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

464	NULL
KIRITO	NULL
ET	NULL
AL	NULL
A	NULL
100	NULL
T	NULL
T	NULL
B	NULL
Q0	NULL
X	NULL
}	NULL
c	NULL
C	NULL
o	NULL
$	NULL
0	NULL
&	NULL
&	NULL
}	NULL
G	NULL
§	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
:	NULL
0	NULL
15	NULL
15	NULL
0	NULL
15	NULL
15	NULL
0	NULL
15	NULL
15	NULL
Probe	NULL
p	NULL
Competitor	NULL
:	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
€	NULL
4	NULL
«	NULL
-	NULL
6	NULL
<	NULL
_	NULL
t	NULL
<	NULL
W	NULL
O	NULL
o	NULL
=	NULL
Am	NULL
SIE	NULL
S	NULL
C	NULL
C	NULL
-=-ss	NULL
°	NULL
atms	NULL
.	NULL

aln	NULL
-	NULL
(	NULL
O	NULL
Win	NULL
als	NULL
Tax	NULL
B-CAP	NULL
-	NULL
»	NULL
We	NULL
l	NULL
GM-CSF	NULL
+-	NULL
-	NULL
--	NULL
’	NULL
EPO	NULL
-	NULL
+	NULL
+	NULL
Fig	NULL
1	NULL
.	NULL

Activation	NULL
by	NULL
GM-CSF	NULL
of	NULL
Statia	NULL
and	NULL
Stat3	NULL
and	NULL
suppression	NULL
by	NULL
GM-CSF	NULL
of	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
UT-7/GM	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
and/	NULL
or	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
.	NULL

Seven	NULL
days	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
dianisidine	NULL
staining	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
means	NULL
+	NULL
standard	NULL
deviation	NULL
(	NULL
SD	NULL
)	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Growth	NULL
factor-starved	NULL
UT-7/GM	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
and/or	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
for	NULL
an	NULL
EMSA	NULL
with	NULL
*°P-labeled	NULL
SIE	NULL
or	NULL
B-CAP	NULL
probes	NULL
.	NULL

Arrows	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
indicate	NULL
a	NULL
homodimer	NULL
of	NULL
Stat3	NULL
,	NULL
a	NULL
heterodimer	NULL
of	NULL
Static	NULL
and	NULL
Stat3	NULL
,	NULL
and	NULL
a	NULL
homodimer	NULL
of	NULL
Stati	NULL
«	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
Kirito	NULL
et	NULL
al'*	NULL
and	NULL
text	NULL
)	NULL
.	NULL

y-globin	NULL
or	NULL
ALAS-E	NULL
mRNA	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
hemoglobin	NULL
synthesis	NULL
.	NULL

EPO	NULL
enhanced	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
both	NULL
genes	NULL
in	NULL
the	NULL
control	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
these	NULL
two	NULL
genes	NULL
were	NULL
elevated	NULL
by	NULL
the	NULL
EPO	NULL
treatment	NULL
of	NULL
Statla	NULL
or	NULL
Stat3	NULL
transfectants	NULL
,	NULL
the	NULL
degree	NULL
of	NULL
elevation	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
in	NULL
the	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
dianisidine-staining	NULL
.	NULL

Statla	NULL
suppressed	NULL
the	NULL
prolongation	NULL
of	NULL
the	NULL
GO/G1	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
after	NULL
EPO	NULL
stimulation	NULL
.	NULL

|	NULL
Cellular	NULL
proliferation	NULL
and	NULL
differentiation	NULL
are	NULL
closely	NULL
associated	NULL
with	NULL
cell	NULL
cycle	NULL
events	NULL
.	NULL

For	NULL
example	NULL
,	NULL
GO/G1	NULL
prolongation	NULL
is	NULL
a	NULL
critical	NULL
event	NULL
for	NULL
erythroid	NULL
differentiation	NULL
.	NULL
``	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
prolongation	NULL
of	NULL
the	NULL
GO/G1	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
was	NULL
required	NULL
for	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL
``	NULL

This	NULL
observation	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
whether	NULL
Stat	NULL
proteins	NULL
inhibited	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
through	NULL
an	NULL
effect	NULL
on	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

After	NULL
the	NULL
24-hour	NULL
deprivation	NULL
of	NULL
growth	NULL
factors	NULL
,	NULL
parent	NULL
UT-7/GM	NULL
or	NULL
transfectant	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
EPO	NULL
for	NULL
various	NULL
periods	NULL
,	NULL
and	NULL
a	NULL
cell	NULL
cycle	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
GO/G1	NULL
cells	NULL
at	NULL
the	NULL
start	NULL
time	NULL
was	NULL
50	NULL
%	NULL
to	NULL
55	NULL
%	NULL
in	NULL
all	NULL
clones	NULL
.	NULL

The	NULL
GO/G1	NULL
percentage	NULL
decreased	NULL
after	NULL
12	NULL
to	NULL
24	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
GM-CSF	NULL
in	NULL
both	NULL
the	NULL
parental	NULL
and	NULL
transfectant	NULL
cells	NULL
(	NULL
Fig	NULL
3A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
a	NULL
large	NULL
difference	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
patterns	NULL
after	NULL
EPO	NULL
treatment	NULL
.	NULL

In	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
and	NULL
Stat3	NULL
transfectant	NULL
cells	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
GO/G1	NULL
cells	NULL
was	NULL
unchanged	NULL
even	NULL
after	NULL
48	NULL
hours	NULL
of	NULL
culture	NULL
with	NULL
EPO	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
Statlo-transfected	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
EPO	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
GO/G1	NULL
cells	NULL
was	NULL
reduced	NULL
to	NULL
35	NULL
%	NULL
to	NULL
40	NULL
%	NULL
after	NULL
24	NULL
to	NULL
48	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
EPO	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

These	NULL
kinetics	NULL
were	NULL
almost	NULL
identical	NULL
to	NULL
those	NULL
produced	NULL
by	NULL
GM-CSF	NULL
treatment	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
may	NULL
explain	NULL
our	NULL
previous	NULL
observation	NULL
that	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
Statlo	NULL
grew	NULL
better	NULL
than	NULL
did	NULL
the	NULL
parent	NULL
or	NULL
Stat3-transfected	NULL
cells	NULL
.	NULL
``	NULL

Activation	NULL
of	NULL
both	NULL
Statla	NULL
and	NULL
Stat3	NULL
additively	NULL
inhibited	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Shortening	NULL
of	NULL
the	NULL
GO/G1	NULL
phase	NULL
after	NULL
EPO	NULL
stimulation	NULL
occurred	NULL
in	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
Statl	NULL
«	NULL
but	NULL
not	NULL
in	NULL
those	NULL
transfected	NULL
with	NULL
Stat3	NULL
cDNA	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
Statle	NULL
and	NULL
Stat3	NULL
inhibit	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
through	NULL
distinct	NULL
pathways	NULL
.	NULL

If	NULL
so	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
Stat	NULL
proteins	NULL
could	NULL
be	NULL
expected	NULL
to	NULL
reduce	NULL
the	NULL
erythroid	NULL
differentiation	NULL
additively	NULL
or	NULL
synergistically	NULL
.	NULL

To	NULL
test	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
introduced	NULL
Stat3	NULL
cDNA	NULL
into	NULL
a	NULL
Statlo-transfected	NULL
clone	NULL
(	NULL
clone	NULL
29	NULL
)	NULL
and	NULL
selected	NULL
3	NULL
independent	NULL
clones	NULL
overexpressing	NULL
both	NULL
Statle	NULL
and	NULL
Stat3	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
constitutive	NULL
activation	NULL
of	NULL
Statlae	NULL
and	NULL
Stat3	NULL
was	NULL
observed	NULL
in	NULL
these	NULL
clones	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
growth	NULL
patterns	NULL
in	NULL
these	NULL
clones	NULL
were	NULL
un-changed	NULL
;	NULL
the	NULL
clone	NULL
cells	NULL
required	NULL
GM-CSF	NULL
or	NULL
EPO	NULL
for	NULL
growth	NULL
and	NULL
survival	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Only	NULL
20	NULL
%	NULL
to	NULL
30	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
became	NULL
dianisidine-positive	NULL
after	NULL
EPO	NULL
treatment	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
cell	NULL
cycle	NULL
patterns	NULL
of	NULL
the	NULL
cells	NULL
doubly	NULL
transfected	NULL
with	NULL
Statle	NULL
and	NULL
Stat3	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
Statla	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
the	NULL
full-length	NULL
EPOR	NULL
also	NULL
decreased	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

-	NULL
Overexpression	NULL
of	NULL
the	NULL
full-length	NULL
EPOR	NULL
(	NULL
UT-7/GM-EPOR	NULL
)	NULL
restored	NULL
the	NULL
growth	NULL
response	NULL
to	NULL
EPO	NULL
in	NULL
UT-7/GM	NULL
cells	NULL
(	NULL
Kirito	NULL
et	NULL
al	NULL
``	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
confirmed	NULL
by	NULL
EMSA	NULL
that	NULL
Statle	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

STAT	NULL
PROTEINS	NULL
AND	NULL
ERYTHROID	NULL
DIFFERENTIATION	NULL
A	NULL
100	NULL
B	NULL
465	NULL
Statio	NULL
.	NULL

#	NULL
29	NULL
#	NULL
32	NULL
#	NULL
47	NULL
Parent	NULL
Days	NULL
in	NULL
culture	NULL
_	NULL
O	NULL
7	NULL
O	NULL
7	NULL
0	NULL
7	NULL
O0	NULL
_	NULL
7	NULL
_	NULL
80	NULL
|	NULL
&	NULL
7	NULL
ALAS-E	NULL
tt	NULL
ao	NULL
[	NULL
)	NULL
8	NULL
y-globin	NULL
Musso	NULL
aas	NULL
$	NULL
60	NULL
Loa	NULL
too	NULL
)	NULL
kin	NULL
ho	NULL
ma	NULL
had	NULL
E	NULL
see	NULL
|	NULL
%	NULL
*	NULL
ib	NULL
Aus	NULL
CB	NULL
in	NULL
W	NULL
O	NULL
7	NULL
5	NULL
p	NULL
©	NULL
@	NULL
40	NULL
J	NULL
g	NULL
Stat3	NULL
5	NULL
#	NULL
5	NULL
#	NULL
12	NULL
#	NULL
29	NULL
_	NULL
Parent	NULL
S	NULL
¥Z	NULL
20	NULL
Days	NULL
in	NULL
culture	NULL
_	NULL
Q	NULL
7	NULL
0	NULL
7	NULL
0	NULL
7	NULL
0	NULL
-	NULL
7	NULL
ALAS-E	NULL
#	NULL
3	NULL
»	NULL
¥	NULL
t	NULL
l	NULL
1	NULL
2	NULL
3	NULL
4	NULL
globin	NULL
|-	NULL
Ses	NULL
ye	NULL
``	NULL
an	NULL
wom	NULL
cue	NULL
sae	NULL
289	NULL
¥	NULL
wp	NULL
v	NULL
»	NULL
ae	NULL
o	NULL
wie	NULL
Fig	NULL
2	NULL
.	NULL

Effects	NULL
of	NULL
overexpression	NULL
of	NULL
Statia	NULL
and/or	NULL
Stat3	NULL
on	NULL
the	NULL
EPO-induced	NULL
differentiation	NULL
of	NULL
UT-7/	NULL
GM	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
UT-7/	NULL
GM	NULL
clones	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
;	NULL
n	NULL
=	NULL
10	NULL
)	NULL
,	NULL
clones	NULL
(	NULL
lane	NULL
2	NULL
;	NULL
n	NULL
=	NULL
10	NULL
)	NULL
,	NULL
Stat3-transfected	NULL
clones	NULL
(	NULL
lane	NULL
3	NULL
;	NULL
n	NULL
=	NULL
10	NULL
)	NULL
,	NULL
and	NULL
Stati	NULL
«	NULL
and	NULL
Stat3-cotransfected	NULL
clones	NULL
(	NULL
lane	NULL
4	NULL
;	NULL
n	NULL
=	NULL
3	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
.	NULL

Seven	NULL
days	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
dianisidine-staining	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Parent	NULL
UT-7/	NULL
GM	NULL
cells	NULL
,	NULL
Stati	NULL
«	NULL
-transfected	NULL
clones	NULL
(	NULL
clones	NULL
29	NULL
,	NULL
32	NULL
,	NULL
and	NULL
47	NULL
)	NULL
,	NULL
and	NULL
Stat3-transfected	NULL
clones	NULL
(	NULL
clones	NULL
5	NULL
,	NULL
12	NULL
,	NULL
and	NULL
29	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
and	NULL
harvested	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
.	NULL

y-Globin	NULL
and	NULL
ALAS-E	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

The	NULL
mem	NULL
brane	NULL
was	NULL
rehybridized	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
human	NULL
ribosomal	NULL
DNA	NULL
probe	NULL
to	NULL
show	NULL
the	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
.	NULL

Stat3	NULL
proteins	NULL
were	NULL
activated	NULL
by	NULL
EPO	NULL
in	NULL
these	NULL
transfectant	NULL
cells	NULL
(	NULL
Kirito	NULL
et	NULL
al	NULL
``	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
EPOR	NULL
overexpression	NULL
affects	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

We	NULL
confirmed	NULL
by	NULL
Northern	NULL
blotting	NULL
that	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
expressed	NULL
EPOR	NULL
at	NULL
low	NULL
levels	NULL
,	NULL
whereas	NULL
the	NULL
transfectant	NULL
cells	NULL
abundantly	NULL
expressed	NULL
EPORs	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

Transfectant	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
EPO	NULL
for	NULL
7	NULL
days	NULL
and	NULL
then	NULL
harvested	NULL
for	NULL
dianisidine	NULL
staining	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
in	NULL
the	NULL
EPOR-transfected	NULL
cells	NULL
were	NULL
much	NULL
lower	NULL
than	NULL
in	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
(	NULL
Fig	NULL
5B	NULL
;	NULL
0	NULL
%	NULL
v	NULL
80	NULL
%	NULL
)	NULL
.	NULL

EPO	NULL
induced	NULL
EPOR	NULL
,	NULL
ALAS-E	NULL
,	NULL
and	NULL
y-globin	NULL
genes	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
in	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
,	NULL
whereas	NULL
neither	NULL
ALAS-E	NULL
nor	NULL
y-globin	NULL
gene	NULL
was	NULL
induced	NULL
in	NULL
the	NULL
EPO-treated	NULL
UT-7/GM-EPOR	NULL
cells	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

This	NULL
result	NULL
was	NULL
consistent	NULL
with	NULL
dianisidine	NULL
staining	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
GO/G1	NULL
was	NULL
clearly	NULL
reduced	NULL
after	NULL
EPO	NULL
treatment	NULL
in	NULL
the	NULL
UT-7/GM-EPOR	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
(	NULL
Fig	NULL
5C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
GO/G1	NULL
prolongation	NULL
did	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
UT-7/GM-EPOR	NULL
cells	NULL
.	NULL

Effect	NULL
of	NULL
dominant	NULL
negative	NULL
forms	NULL
of	NULL
Statla	NULL
and	NULL
Stat3	NULL
on	NULL
the	NULL
inhibition	NULL
by	NULL
GM-CSF	NULL
of	NULL
EPO-induced	NULL
erythroid	NULL
differentia-	NULL
tion	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
Stat1lF	NULL
and	NULL
Stat3F	NULL
function	NULL
as	NULL
the	NULL
dominant	NULL
negative	NULL
forms	NULL
in	NULL
our	NULL
we	NULL
cotransfected	NULL
these	NULL
cDNAs	NULL
and	NULL
4XAPREIuc	NULL
into	NULL
the	NULL
parent	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

After	NULL
24	NULL
hours	NULL
of	NULL
starvation	NULL
,	NULL
these	NULL
transfectant	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
6	NULL
hours	NULL
later	NULL
for	NULL
a	NULL
luciferase	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
6A	NULL
,	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
clearly	NULL
reduced	NULL
in	NULL
the	NULL
Stat1F	NULL
and	NULL
Stat3F	NULL
transfectant	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
dominant-negative	NULL
forms	NULL
work	NULL
well	NULL
in	NULL
our	NULL
system	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
confirmed	NULL
by	NULL
EMSA	NULL
that	NULL
the	NULL
dominant-negative	NULL
Stats	NULL
actually	NULL
inhibited	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
the	NULL
wild-type	NULL
Stats	NULL
in	NULL
UT-7/GM	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
in	NULL
erythroid	NULL
differentiation	NULL
,	NULL
we	NULL
generated	NULL
stable	NULL
transfectant	NULL
cells	NULL
exogenously	NULL
expressing	NULL
StatlF	NULL
or	NULL
Stat3F	NULL
.	NULL

An	NULL
MTT	NULL
assay	NULL
showed	NULL
that	NULL
Stat1lF	NULL
but	NULL
not	NULL
Stat3F	NULL
partially	NULL
inhibited	NULL
the	NULL
GM-CSF-induced	NULL
cell	NULL
growth	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

Then	NULL
,	NULL
these	NULL
transfectant	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
alone	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
,	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
and	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
for	NULL
7	NULL
days	NULL
and	NULL
then	NULL
harvested	NULL
for	NULL
dianisidine	NULL
staining	NULL
.	NULL

GM-CSF	NULL
completely	NULL
blocked	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
in	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

466	NULL
KIRITO	NULL
ET	NULL
AL	NULL
A	NULL
GM-CSF	NULL
EPO	NULL
55	NULL
®	NULL
UT-7/GM	NULL
69	NULL
[	NULL
®	NULL
UT-z/GMm	NULL
O	NULL
Clone	NULL
29	NULL
O	NULL
Clone	NULL
29	NULL
E	NULL
Clone	NULL
47	NULL
Eq	NULL
Clone	NULL
47	NULL
Percentage	NULL
of	NULL
cells	NULL
in	NULL
GO/G1	NULL
Percentage	NULL
of	NULL
cells	NULL
in	NULL
GO/G1	NULL
0	NULL
12	NULL
24	NULL
36	NULL
48	NULL
0	NULL
12	NULL
Time	NULL
in	NULL
culture	NULL
(	NULL
hr	NULL
)	NULL
35__|___I___I__l	NULL
36	NULL
-	NULL
48	NULL
Time	NULL
in	NULL
culture	NULL
(	NULL
hr	NULL
)	NULL
B	NULL
GM-CSF	NULL
EPO	NULL
55	NULL
[	NULL
®	NULL
UT-7/GM	NULL
60	NULL
r	NULL
®	NULL
UT-7/GM	NULL
O	NULL
Clone	NULL
5	NULL
O	NULL
Clone	NULL
5	NULL
E	NULL
]	NULL
Clone	NULL
29	NULL
EF	NULL
Clone	NULL
29	NULL
8	NULL
g	NULL
)	NULL
.	NULL

a	NULL
Ig—ll	NULL
Percentage	NULL
of	NULL
cells	NULL
in	NULL
GO/G1	NULL
p	NULL
O	NULL
Percentage	NULL
of	NULL
cells	NULL
in	NULL
GO/G1	NULL
0	NULL
12	NULL
-	NULL
24	NULL
-	NULL
36	NULL
-	NULL
48	NULL
0	NULL
12	NULL
Time	NULL
in	NULL
culture	NULL
(	NULL
hr	NULL
)	NULL
However	NULL
,	NULL
unlike	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
,	NULL
about	NULL
20	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
Stat1F	NULL
or	NULL
Stat3F	NULL
showed	NULL
the	NULL
positivity	NULL
for	NULL
dianisidine	NULL
staining	NULL
after	NULL
exposure	NULL
to	NULL
EPO	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
6C	NULL
)	NULL
.	NULL

Approximately	NULL
80	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
treated	NULL
with	NULL
EPO	NULL
became	NULL
positive	NULL
for	NULL
dianidisine	NULL
staining	NULL
in	NULL
these	NULL
transfectant	NULL
cells	NULL
(	NULL
Stat1lF	NULL
,	NULL
75.0	NULL
%	NULL
+	NULL
2.7	NULL
%	NULL
;	NULL
Stat3F	NULL
,	NULL
75.4	NULL
%	NULL
5.0	NULL
%	NULL
)	NULL
,	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
(	NULL
76.5	NULL
%	NULL
+	NULL
8.7	NULL
%	NULL
)	NULL
.	NULL

+	NULL
1+	NULL
DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
established	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
Stat	NULL
proteins	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

The	NULL
forced	NULL
activation	NULL
of	NULL
Statle	NULL
and/or	NULL
Stat3	NULL
suppressed	NULL
the	NULL
induction	NULL
of	NULL
y-globin	NULL
and	NULL
the	NULL
erythroid-specific	NULL
ALAS	NULL
gene	NULL
,	NULL
resulting	NULL
in	NULL
decreased	NULL
hemoglobin	NULL
synthesis	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
UT-7/GM	NULL
cells	NULL
transfected	NULL
with	NULL
EPOR	NULL
cDNA	NULL
restored	NULL
the	NULL
EPO-induced	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
and	NULL
acquired	NULL
high	NULL
responsiveness	NULL
to	NULL
EPO	NULL
for	NULL
cell	NULL
proliferation	NULL
.	NULL

However	NULL
,	NULL
these	NULL
cells	NULL
lost	NULL
their	NULL
capacity	NULL
to	NULL
become	NULL
hemoglobin-positive	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
35—1___I—I—J	NULL
Time	NULL
in	NULL
culture	NULL
(	NULL
hr	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Cell	NULL
cycle	NULL
analysis	NULL
.	NULL

Parental	NULL
UT-7/	NULL
GM	NULL
cells	NULL
,	NULL
Stati	NULL
«	NULL
-transfected	NULL
clones	NULL
(	NULL
A	NULL
;	NULL
clones	NULL
29	NULL
and	NULL
47	NULL
)	NULL
,	NULL
or	NULL
Stat3-transfected	NULL
clones	NULL
(	NULL
B	NULL
;	NULL
clones	NULL
5	NULL
and	NULL
29	NULL
)	NULL
were	NULL
starved	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
subsequently	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
and	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
for	NULL
cell	NULL
cycle	NULL
analysis	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
G0/G1	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
ModFit	NULL
LT	NULL
program	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

36	NULL
-	NULL
48	NULL
EPO	NULL
.	NULL

Dominant	NULL
negative	NULL
forms	NULL
of	NULL
Statla	NULL
«	NULL
or	NULL
Stat3	NULL
promoted	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
both	NULL
Statle	NULL
and	NULL
Stat	NULL
3	NULL
act	NULL
as	NULL
negative	NULL
regulators	NULL
of	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
cellular	NULL
switch	NULL
to	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
Carroll	NULL
et	NULL
al	NULL
``	NULL
``	NULL
reported	NULL
that	NULL
prolongation	NULL
of	NULL
the	NULL
GO/G1	NULL
phase	NULL
was	NULL
required	NULL
for	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

We	NULL
recently	NULL
found	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
GM-CSF	NULL
reduced	NULL
the	NULL
GO/G1	NULL
prolongation	NULL
,	NULL
accompanied	NULL
by	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
showed	NULL
here	NULL
that	NULL
the	NULL
inhibition	NULL
by	NULL
GM-CSF	NULL
of	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
correlated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
Statlae	NULL
and	NULL
Stat3	NULL
(	NULL
Fig	NULL
1A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
Statle	NULL
promoted	NULL
the	NULL
entry	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

This	NULL
notion	NULL
was	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
Stat1F	NULL
but	NULL
not	NULL
Stat3F	NULL
inhibited	NULL
the	NULL
GM-CSF-induced	NULL
cell	NULL
growth	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
reports	NULL
that	NULL
Statla	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
proliferative	NULL
effects	NULL
of	NULL
platelet-derived	NULL
growth	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

STAT	NULL
PROTEINS	NULL
AND	NULL
ERYTHROID	NULL
DIFFERENTIATION	NULL
STAT	NULL
Parent	NULL
STKTB	NULL
GM-CSF	NULL
-+-	NULL
-	NULL
+-EPO	NULL
=	NULL
=	NULL
4+	NULL
=	NULL
-=-	NULL
+	NULL
¥	NULL
»	NULL
a	NULL
»	NULL
&	NULL
»	NULL
an	NULL
AUD	NULL
46	NULL
iE	NULL
]	NULL
.	NULL

e0e	NULL
Fig	NULL
4	NULL
.	NULL

Establishment	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
coexpressing	NULL
Static	NULL
and	NULL
Stat3	NULL
.	NULL

UT-7/GM	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
Statice	NULL
and	NULL
Stat3	NULL
cDNA	NULL
.	NULL

UT-7/GM	NULL
and	NULL
transfectant	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
growth	NULL
factors	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
or	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
from	NULL
the	NULL
cells	NULL
,	NULL
and	NULL
an	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
*°P-labeled	NULL
SIE	NULL
probes	NULL
.	NULL

«	NULL
ie	NULL
factor	NULL
(	NULL
PDGF	NULL
)	NULL
and	NULL
epidermal	NULL
growth	NULL
factor	NULL
(	NULL
EGF	NULL
)	NULL
,	NULL
``	NULL
our	NULL
data	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
Statl	NULL
«	NULL
is	NULL
directly	NULL
or	NULL
indirectly	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
cell	NULL
cycle-associated	NULL
gene	NULL
transcription	NULL
.	NULL

There	NULL
are	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
Stat	NULL
proteins	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

It	NULL
was	NULL
demonstrated	NULL
that	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
inhibited	NULL
growth	NULL
arrest	NULL
at	NULL
the	NULL
GO/G1	NULL
phase	NULL
induced	NULL
by	NULL
IL-6	NULL
in	NULL
a	NULL
murine	NULL
leukemic	NULL
cell	NULL
line	NULL
,	NULL
M1	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
another	NULL
group	NULL
reported	NULL
the	NULL
EGF-	NULL
or	NULL
inter-feron-y	NULL
(	NULL
IFN-y	NULL
)	NULL
-induced	NULL
growth	NULL
arrest	NULL
of	NULL
A431	NULL
or	NULL
HT29	NULL
cells	NULL
by	NULL
the	NULL
upregulation	NULL
of	NULL
the	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitor	NULL
,	NULL
p21	NULL
;	NULL
this	NULL
was	NULL
mediated	NULL
through	NULL
the	NULL
binding	NULL
of	NULL
activated	NULL
Statla	NULL
to	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
p21	NULL
gene	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
Statle	NULL
and	NULL
Stat3	NULL
proteins	NULL
appear	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
blockade	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

However	NULL
,	NULL
this	NULL
notion	NULL
is	NULL
inconsistent	NULL
with	NULL
our	NULL
present	NULL
finding	NULL
that	NULL
Statla	NULL
proteins	NULL
promoted	NULL
entry	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

This	NULL
discrepancy	NULL
may	NULL
be	NULL
explained	NULL
partly	NULL
by	NULL
the	NULL
evidence	NULL
that	NULL
p21	NULL
acts	NULL
not	NULL
only	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
,	NULL
but	NULL
also	NULL
as	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

``	NULL
>	NULL
**	NULL
It	NULL
is	NULL
apparent	NULL
that	NULL
the	NULL
inhibition	NULL
by	NULL
Stat3	NULL
of	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
is	NULL
independent	NULL
on	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
forced	NULL
overexpression	NULL
of	NULL
Stat3	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
EPO-induced	NULL
proliferation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
Stat3	NULL
promotes	NULL
the	NULL
differentiation	NULL
of	NULL
M1	NULL
cells	NULL
to	NULL
macrophages	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
it	NULL
was	NULL
found	NULL
that	NULL
Stat3	NULL
inhibits	NULL
the	NULL
neural	NULL
differentiation	NULL
of	NULL
PC12	NULL
cells	NULL
.	NULL
``	NULL

Whereas	NULL
all	NULL
of	NULL
these	NULL
data	NULL
were	NULL
obtained	NULL
using	NULL
immortalized	NULL
cell	NULL
lines	NULL
,	NULL
it	NULL
was	NULL
recently	NULL
shown	NULL
that	NULL
Stat3	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
maintenance	NULL
of	NULL
embryonic	NULL
stem	NULL
(	NULL
ES	NULL
)	NULL
cells	NULL
by	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
(	NULL
LIF	NULL
)	NULL
;	NULL
the	NULL
Stat3	NULL
dominant-negative	NULL
form	NULL
induced	NULL
morphological	NULL
differentiation	NULL
of	NULL
ES	NULL
cells	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LIF	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
Stat3	NULL
on	NULL
differentiation	NULL
are	NULL
limited	NULL
to	NULL
immortalized	NULL
cells	NULL
.	NULL

Stat3	NULL
could	NULL
also	NULL
be	NULL
expected	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
normal	NULL
development	NULL
,	NULL
presumably	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
differentiation	NULL
.	NULL

Although	NULL
the	NULL
dominant-negative	NULL
forms	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
467	NULL
certainly	NULL
inhibited	NULL
the	NULL
GM-CSF-induced	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
transfectant	NULL
cells	NULL
did	NULL
not	NULL
become	NULL
dianisidine-positive	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
alone	NULL
,	NULL
as	NULL
was	NULL
the	NULL
case	NULL
for	NULL
the	NULL
parental	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
the	NULL
parent	NULL
cells	NULL
,	NULL
about	NULL
20	NULL
%	NULL
of	NULL
the	NULL
transfectant	NULL
cells	NULL
became	NULL
dianidisine-positive	NULL
after	NULL
exposure	NULL
to	NULL
EPO	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
6C	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
activation	NULL
of	NULL
Statl	NULL
«	NULL
and	NULL
Stat3	NULL
is	NULL
required	NULL
,	NULL
but	NULL
is	NULL
not	NULL
sufficient	NULL
by	NULL
itself	NULL
,	NULL
for	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
,	NULL
and	NULL
that	NULL
the	NULL
EPO	NULL
signal	NULL
(	NULL
s	NULL
)	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
erythroid	NULL
differentiation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
proteins	NULL
partially	NULL
but	NULL
not	NULL
completely	NULL
inhibited	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
suggests	NULL
that	NULL
other	NULL
molecules	NULL
such	NULL
as	NULL
Lyn®®	NULL
and	NULL
SHP-1*	NULL
``	NULL
may	NULL
be	NULL
in	NULL
part	NULL
involved	NULL
in	NULL
the	NULL
suppression	NULL
by	NULL
GM-CSF	NULL
of	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

The	NULL
constitutive	NULL
activation	NULL
of	NULL
Statla	NULL
or	NULL
Stat3	NULL
is	NULL
frequently	NULL
observed	NULL
in	NULL
leukemia	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
In	NULL
addition	NULL
,	NULL
Statla	NULL
and	NULL
Stat3	NULL
are	NULL
activated	NULL
by	NULL
Ber-Abl	NULL
products*	NULL
'	NULL
and	NULL
src-kinase	NULL
,	NULL
``	NULL
>	NULL
``	NULL
``	NULL
respec-tively	NULL
.	NULL

The	NULL
infection	NULL
of	NULL
Friend	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
in	NULL
the	NULL
EPO-dependent	NULL
murine	NULL
cell	NULL
line	NULL
HCD	NULL
57	NULL
causes	NULL
cytokine-independent	NULL
cell	NULL
growth	NULL
and	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
.	NULL

``	NULL
*	NULL
A	NULL
mutation	NULL
in	NULL
the	NULL
Drosophilia	NULL
homolog	NULL
of	NULL
the	NULL
JAK	NULL
kinase	NULL
gene	NULL
causes	NULL
the	NULL
hyperactivation	NULL
of	NULL
this	NULL
signal	NULL
transduction	NULL
pathway	NULL
and	NULL
subsequent	NULL
leukemia-like	NULL
hematopoietic	NULL
defects	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
aberrations	NULL
in	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
could	NULL
cause	NULL
the	NULL
development	NULL
of	NULL
hematologic	NULL
malignancy	NULL
.	NULL

Although	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Statle	NULL
and/or	NULL
Stat3	NULL
blocked	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
these	NULL
transfectant	NULL
cells	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
autonomous	NULL
cell	NULL
growth	NULL
(	NULL
Kirito	NULL
et	NULL
al	NULL
``	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Statle	NULL
and/or	NULL
Stat3	NULL
is	NULL
insufficient	NULL
for	NULL
the	NULL
autonomous	NULL
growth	NULL
of	NULL
leukemia	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
exogenous	NULL
expression	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
in	NULL
UT-7/GM	NULL
cells	NULL
resulted	NULL
in	NULL
constitutive	NULL
activation	NULL
of	NULL
these	NULL
molecules	NULL
is	NULL
unknown	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Because	NULL
mere	NULL
overexpression	NULL
of	NULL
Stat	NULL
molecules	NULL
,	NULL
even	NULL
in	NULL
COS	NULL
cells	NULL
,	NULL
usually	NULL
does	NULL
not	NULL
give	NULL
rise	NULL
to	NULL
constitutive	NULL
activation	NULL
,	NULL
the	NULL
overexpressed	NULL
Statle	NULL
and	NULL
Stat3	NULL
proteins	NULL
might	NULL
be	NULL
showing	NULL
the	NULL
action	NULL
of	NULL
normally	NULL
subthreshold	NULL
amounts	NULL
of	NULL
an	NULL
autocrine	NULL
factor	NULL
.	NULL

Because	NULL
Stat3	NULL
knockout	NULL
mice	NULL
have	NULL
a	NULL
lethal	NULL
defect	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
estimate	NULL
the	NULL
function	NULL
of	NULL
Stat3	NULL
on	NULL
erythropoiesis	NULL
.	NULL
``	NULL

Statlae	NULL
knockout	NULL
mice	NULL
studies	NULL
demonstrated	NULL
that	NULL
the	NULL
elimination	NULL
of	NULL
the	NULL
Stat	NULL
genes	NULL
does	NULL
not	NULL
affect	NULL
erythropoiesis.4	NULL
``	NULL
``	NULL
This	NULL
seems	NULL
to	NULL
contradict	NULL
our	NULL
observation	NULL
.	NULL

This	NULL
discrepancy	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
two	NULL
possibilities	NULL
.	NULL

One	NULL
is	NULL
that	NULL
other	NULL
Stat	NULL
proteins	NULL
such	NULL
as	NULL
Stat3	NULL
compensate	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
Statle	NULL
.	NULL

The	NULL
other	NULL
is	NULL
that	NULL
Statla	NULL
is	NULL
involved	NULL
in	NULL
abnormal	NULL
erythropoiesis	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
results	NULL
obtained	NULL
using	NULL
leukemic	NULL
cell	NULL
line	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
also	NULL
interesting	NULL
that	NULL
most	NULL
of	NULL
the	NULL
UT-7/GM	NULL
cells	NULL
lost	NULL
the	NULL
capacity	NULL
to	NULL
differentiate	NULL
into	NULL
erythroid	NULL
cells	NULL
by	NULL
overexpression	NULL
of	NULL
the	NULL
full-length	NULL
EPOR	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
these	NULL
transfectant	NULL
cells	NULL
had	NULL
a	NULL
restored	NULL
growth	NULL
response	NULL
to	NULL
EPO	NULL
and	NULL
activation	NULL
of	NULL
Statla	NULL
and	NULL
Stat3	NULL
by	NULL
EPO	NULL
.	NULL
``	NULL

This	NULL
indicates	NULL
that	NULL
Statle	NULL
and	NULL
Stat3	NULL
lie	NULL
downstream	NULL
of	NULL
the	NULL
EPO	NULL
receptor	NULL
in	NULL
the	NULL
EPO	NULL
signaling	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
Stat3-Stat3	NULL
homodimers	NULL
were	NULL
almost	NULL
undetectable	NULL
in	NULL
the	NULL
EPO-treated	NULL
UT-7/GM-EPOR	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
one	NULL
possibility	NULL
that	NULL
the	NULL
ratio	NULL
of	NULL
activated	NULL
Stat3	NULL
to	NULL
activated	NULL
Statla	NULL
by	NULL
EPO	NULL
is	NULL
relatively	NULL
small	NULL
,	NULL
resulting	NULL
in	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

468	NULL
Days	NULL
in	NULL
culture	NULL
EPOR	NULL
ALAS-E	NULL
y-globin	NULL
2858	NULL
GM-CSF	NULL
O	NULL
55	NULL
60	NULL
[	NULL
©	NULL
UT-7/GM	NULL
{	NULL
UT-7/GM	NULL
EPOR	NULL
55	NULL
|	NULL
50	NULL
45	NULL
|	NULL
Percentage	NULL
of	NULL
cells	NULL
in	NULL
GO/G1	NULL
Percentage	NULL
of	NULL
cells	NULL
in	NULL
GO/G1	NULL
40	NULL
30	NULL
0	NULL
35	NULL
12	NULL
24	NULL
36	NULL
-	NULL
48	NULL
12	NULL
Time	NULL
in	NULL
culture	NULL
(	NULL
hr	NULL
)	NULL
the	NULL
increased	NULL
formation	NULL
of	NULL
Statle-Stat3	NULL
heterodimers	NULL
and	NULL
the	NULL
decreased	NULL
formation	NULL
of	NULL
Stat3-Stat3	NULL
homodimers	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
EPO	NULL
is	NULL
due	NULL
to	NULL
low	NULL
levels	NULL
of	NULL
endogenous	NULL
EPO	NULL
receptor	NULL
expression	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
completely	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
decreased	NULL
sensitivity	NULL
to	NULL
EPO	NULL
is	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
endogenous	NULL
EPO	NULL
receptor	NULL
,	NULL
we	NULL
and	NULL
another	NULL
group	NULL
demonstrated	NULL
that	NULL
the	NULL
original	NULL
UT-7	NULL
cells	NULL
expressed	NULL
structurally	NULL
normal	NULL
EPOR	NULL
mRNA	NULL
.	NULL
``	NULL

Whether	NULL
Stat5	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
is	NULL
still	NULL
controversial	NULL
.	NULL

Chretien	NULL
et	NULL
al	NULL
'*	NULL
reported	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
Stats	NULL
promotes	NULL
cell	NULL
growth	NULL
and	NULL
inhibits	NULL
erythroid	NULL
differentiation	NULL
in	NULL
a	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
Iwatsuki	NULL
et	NULL
al	NULL
``	NULL
``	NULL
found	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
Stat5	NULL
leads	NULL
to	NULL
erythroid	NULL
differentiation	NULL
in	NULL
a	NULL
murine	NULL
erythroleukemia	NULL
KIRITO	NULL
ET	NULL
AL	NULL
B	NULL
100	NULL
80	NULL
60	NULL
40	NULL
20	NULL
Dianisidine-Positive	NULL
Cells	NULL
(	NULL
%	NULL
)	NULL
0	NULL
UT-7/GM	NULL
UT-7/GM	NULL
EPOR	NULL
EPO	NULL
©	NULL
UT-7/GM	NULL
C	NULL
UT-7/GM	NULL
EPOR	NULL
24	NULL
Time	NULL
in	NULL
culture	NULL
(	NULL
hr	NULL
)	NULL
Fig	NULL
5	NULL
.	NULL

Effects	NULL
of	NULL
overexpression	NULL
of	NULL
EPOR	NULL
on	NULL
the	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Parent	NULL
UT-7/GM	NULL
and	NULL
UT-7/GM-EPOR	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
for	NULL
7	NULL
days	NULL
,	NULL
and	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

The	NULL
transcripts	NULL
of	NULL
EPOR	NULL
,	NULL
ALAS-E	NULL
,	NULL
and	NULL
y-globin	NULL
w	NULL
ere	NULL
examined	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
rehybridized	NULL
with	NULL
a	NULL
*P-labeled	NULL
human	NULL
ribosomal	NULL
DNA	NULL
probe	NULL
to	NULL
show	NULL
the	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Dianisidine-staining	NULL
.	NULL

UT-7/	NULL
GM-EPOR	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
10	NULL
U/mL	NULL
of	NULL
EPO	NULL
for	NULL
7	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
dianisidine	NULL
staining	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Parent	NULL
UT-7/GM	NULL
cells	NULL
and	NULL
UT-7/GM-EPOR	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
and	NULL
harvested	NULL
for	NULL
cell	NULL
cycle	NULL
analysis	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
G0/G1	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

36	NULL
-	NULL
48	NULL
cell	NULL
line	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
EPO	NULL
induced	NULL
erythroid	NULL
differentiation	NULL
in	NULL
UT-7/GM	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
UT-7	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
degree	NULL
of	NULL
Stat5	NULL
activation	NULL
by	NULL
EPO	NULL
between	NULL
these	NULL
cell	NULL
lines	NULL
(	NULL
Kirito	NULL
et	NULL
al	NULL
'	NULL
``	NULL
?	NULL

and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
discrepancy	NULL
is	NULL
caused	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
completely	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
Stat5	NULL
activation	NULL
is	NULL
insufficient	NULL
for	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

A	NULL
separate	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
is	NULL
required	NULL
for	NULL
the	NULL
terminal	NULL
maturation	NULL
of	NULL
erythroid	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
still	NULL
controversial	NULL
as	NULL
to	NULL
whether	NULL
EPO	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
Statle	NULL
and/or	NULL
Stat3	NULL
as	NULL
well	NULL
as	NULL
Stat5	NULL
.	NULL

Some	NULL
investigators	NULL
reported	NULL
that	NULL
Stat5	NULL
,	NULL
but	NULL
not	NULL
Statle	NULL
or	NULL
Stat3	NULL
,	NULL
is	NULL
activated	NULL
by	NULL
EPO	NULL
in	NULL
Ba/F3	NULL
cells	NULL
transfected	NULL
with	NULL
EPOR	NULL
cDNA	NULL
.	NULL
``	NULL

To	NULL
test	NULL
this	NULL
,	NULL
we	NULL
also	NULL
generated	NULL
Ba/F3	NULL
cells	NULL
exogenously	NULL
expressing	NULL
human	NULL
EPOR	NULL
and	NULL
examined	NULL
whether	NULL
EPO	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

STAT	NULL
PROTEINS	NULL
AND	NULL
ERYTHROID	NULL
DIFFERENTIATION	NULL
A	NULL
Relative	NULL
Promoter	NULL
activity	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
o	NULL
o	NULL
O	NULL
Co	NULL
MTT	NULL
Reduction	NULL
(	NULL
ODsgsnm	NULL
)	NULL
o	NULL
p	NULL
Fad	NULL
to	NULL
&	NULL
tn	NULL
U	NULL
ro	NULL
UJ	NULL
\\'§	NULL
I	NULL
I	NULL
_	NULL
_	NULL
5	NULL
Control	NULL
Stat1iF	NULL
Stat3F	NULL
Parent	NULL
Stat1F	NULL
Stat3F	NULL
469	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
dominant-negative	NULL
forms	NULL
of	NULL
Static	NULL
and	NULL
Stat3	NULL
on	NULL
the	NULL
inhibition	NULL
by	NULL
GM-CSF	NULL
of	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
UT-7/	NULL
GM	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
DNA	NULL
mixture	NULL
(	NULL
1	NULL
ug	NULL
of	NULL
reporter	NULL
genes	NULL
containing	NULL
4	NULL
copies	NULL
of	NULL
APRE	NULL
in	NULL
front	NULL
of	NULL
the	NULL
minimal	NULL
JunB	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
either	NULL
expression	NULL
vector	NULL
pCAGGS-Neo	NULL
,	NULL
with	NULL
no	NULL
insert	NULL
or	NULL
with	NULL
an	NULL
insert	NULL
of	NULL
Stat	NULL
cDNA	NULL
encoding	NULL
either	NULL
HA-Stat3F	NULL
or	NULL
HA-Stat1F	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
pSV-B-galactosidase	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
without	NULL
growth	NULL
factors	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

Luciferase	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
and	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
normalized	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmids	NULL
and	NULL
a	NULL
control	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
more	NULL
than	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
MTT	NULL
reduction	NULL
assay	NULL
.	NULL

Cells	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10/	NULL
well	NULL
in	NULL
IMDM	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
and	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
.	NULL

MTT	NULL
reduction	NULL
was	NULL
measured	NULL
after	NULL
3	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Dianidisine	NULL
staining	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
EPO	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
and	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
.	NULL

Seven	NULL
days	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
dianisidine	NULL
staining	NULL
.	NULL

The	NULL
data	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
from	NULL
three	NULL
independent	NULL
clones	NULL
.	NULL

025	NULL
T	NULL
T	NULL
M-CSF	NULL
M-CSF+EPO	NULL
O0	NULL
a	NULL
&	NULL
G	NULL
Do	NULL
O	NULL
T	NULL
_i	NULL
_a	NULL
O	NULL
on	NULL
Dianisidine-Positive	NULL
Cells	NULL
(	NULL
%	NULL
)	NULL
&	NULL
n	NULL
Parent	NULL
Stat1F	NULL
Stat3F	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

470	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
proteins	NULL
in	NULL
these	NULL
transfectant	NULL
cells	NULL
.	NULL

As	NULL
reported	NULL
previously	NULL
,	NULL
neither	NULL
of	NULL
these	NULL
Stat	NULL
proteins	NULL
was	NULL
activated	NULL
by	NULL
EPO	NULL
stimulation	NULL
,	NULL
although	NULL
Stat5	NULL
protein	NULL
was	NULL
strongly	NULL
activated	NULL
by	NULL
EPO	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
data	NULL
obtained	NULL
from	NULL
Ba/F3	NULL
transfectant	NULL
cells	NULL
were	NULL
in	NULL
contrast	NULL
with	NULL
those	NULL
from	NULL
the	NULL
UT-7	NULL
cells	NULL
expressing	NULL
endogenous	NULL
human	NULL
EPOR	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
completely	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
discrepancy	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
or	NULL
the	NULL
different	NULL
EPOR	NULL
number	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
EPO	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
Statle	NULL
and/or	NULL
Stat3	NULL
proteins	NULL
in	NULL
primary	NULL
erythroid	NULL
cells	NULL
and	NULL
cell	NULL
lines	NULL
abundantly	NULL
expressing	NULL
endogenous	NULL
EPOR.134455.56	NULL
In	NULL
summary	NULL
,	NULL
we	NULL
propose	NULL
a	NULL
novel	NULL
function	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
a	NULL
leukemia	NULL
cell	NULL
line	NULL
;	NULL
Statle	NULL
may	NULL
inhibit	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
,	NULL
presumably	NULL
mediated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
cell	NULL
cycle-associated	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
roles	NULL
of	NULL
Statle	NULL
and	NULL
Stat3	NULL
in	NULL
normal	NULL
erythropoiesis	NULL
remains	NULL
to	NULL
be	NULL
undetermined	NULL
,	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
these	NULL
Stat	NULL
proteins	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
erythroid	NULL
differentiation	NULL
arrest	NULL
in	NULL
erythroleukemia	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
the	NULL
Life	NULL
Science	NULL
Research	NULL
Institute	NULL
of	NULL
Snow	NULL
Brand	NULL
Milk	NULL
Co	NULL
for	NULL
providing	NULL
recombinant	NULL
human	NULL
EPO	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
Tomoko	NULL
Ando	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
Motoko	NULL
Yoshida	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Koury	NULL
MJ	NULL
,	NULL
Bondurant	NULL
MC	NULL
:	NULL
Maintenance	NULL
by	NULL
erythropoietin	NULL
of	NULL
viability	NULL
and	NULL
maturation	NULL
of	NULL
murine	NULL
erythroid	NULL
precursor	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
137:65	NULL
,	NULL
1988	NULL
2	NULL
.	NULL

Miura	NULL
O0	NULL
,	NULL
Nakamura	NULL
N	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Thle	NULL
JN	NULL
,	NULL
Aoki	NULL
N	NULL
:	NULL
Erythropoietin	NULL
induces	NULL
association	NULL
of	NULL
the	NULL
JAK2	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
with	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
in	NULL
vivo	NULL
.	NULL

Blood	NULL
84:1501	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Gouilleux	NULL
F	NULL
,	NULL
Pallard	NULL
C	NULL
,	NULL
Dusanter	NULL
FI	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
Haldosen	NULL
LA	NULL
,	NULL
Norstedt	NULL
G	NULL
,	NULL
Levy	NULL
D	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
erythropoietin	NULL
and	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
induce	NULL
MGF-Stat5	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
14:2005	NULL
,	NULL
1995	NULL
4	NULL
.	NULL

Pallard	NULL
C	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Charon	NULL
M	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Dusanter	NULL
FI	NULL
:	NULL
Interleukin-3	NULL
,	NULL
erythropoietin	NULL
,	NULL
and	NULL
prolactin	NULL
activate	NULL
a	NULL
STAT	NULL
factor	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:15942	NULL
,	NULL
1995	NULL
5	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Harada	NULL
N	NULL
,	NULL
Kitamura	NULL
T	NULL
,	NULL
Mui	NULL
AL	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
Interleukin	NULL
2	NULL
and	NULL
erythropoietin	NULL
activate	NULL
STATS/MGF	NULL
via	NULL
distinct	NULL
pathways	NULL
.	NULL

EMBO	NULL
J	NULL
14:2527	NULL
,	NULL
1995	NULL
6	NULL
.	NULL

Miura	NULL
Y	NULL
,	NULL
Miura	NULL
O	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Aoki	NULL
N	NULL
:	NULL
Activation	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
by	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:29962	NULL
,	NULL
1994	NULL
7	NULL
.	NULL

Ren	NULL
H-Y	NULL
,	NULL
Komatsu	NULL
N	NULL
,	NULL
Shimizu	NULL
R	NULL
,	NULL
Okada	NULL
K	NULL
,	NULL
Miura	NULL
Y	NULL
:	NULL
Erythropoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
phospholipase	NULL
C-y1	NULL
in	NULL
a	NULL
human	NULL
erythropoietin-dependent	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:19633	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Schindler	NULL
C	NULL
,	NULL
Fu	NULL
XY	NULL
,	NULL
Improta	NULL
T	NULL
,	NULL
Aebersold	NULL
R	NULL
,	NULL
Darnell	NULL
JEJ	NULL
:	NULL
Proteins	NULL
of	NULL
transcription	NULL
factor	NULL
ISGF-3	NULL
:	NULL
One	NULL
gene	NULL
encodes	NULL
the	NULL
91	NULL
and	NULL
84-kDa	NULL
ISGF-3	NULL
proteins	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
interferon	NULL
«	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:7836	NULL
,	NULL
1992	NULL
9	NULL
.	NULL

Fu	NULL
XY	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Improta	NULL
T	NULL
,	NULL
Aebersold	NULL
R	NULL
,	NULL
Darnell	NULL
JEJ	NULL
:	NULL
The	NULL
proteins	NULL
of	NULL
ISGF-3	NULL
,	NULL
the	NULL
interferon	NULL
-induced	NULL
transcriptional	NULL
activator	NULL
,	NULL
define	NULL
a	NULL
gene	NULL
family	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:7840	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Komatsu	NULL
N	NULL
,	NULL
Nakauchi	NULL
H	NULL
,	NULL
Miwa	NULL
A	NULL
,	NULL
Ishihara	NULL
T	NULL
,	NULL
Eguchi	NULL
M	NULL
,	NULL
Moroi	NULL
M	NULL
,	NULL
Okada	NULL
M	NULL
,	NULL
Sato	NULL
Y	NULL
,	NULL
Wada	NULL
H	NULL
,	NULL
Yawata	NULL
Y	NULL
,	NULL
Suda	NULL
T	NULL
,	NULL
Miura	NULL
Y	NULL
:	NULL
Establish	NULL
KIRITO	NULL
ET	NULL
AL	NULL
ment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
with	NULL
megakaryocytic	NULL
features	NULL
:	NULL
Dependency	NULL
on	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
interleukin	NULL
3	NULL
,	NULL
or	NULL
erythropoietin	NULL
for	NULL
growth	NULL
and	NULL
survival	NULL
.	NULL

Cancer	NULL
Res	NULL
51:341	NULL
,	NULL
1991	NULL
11	NULL
.	NULL

Komatsu	NULL
N	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Fujita	NULL
H	NULL
,	NULL
Miwa	NULL
A	NULL
,	NULL
Hatake	NULL
K	NULL
,	NULL
Endo	NULL
T	NULL
,	NULL
Okano	NULL
H	NULL
,	NULL
Katsube	NULL
T	NULL
,	NULL
Fukumaki	NULL
Y	NULL
,	NULL
Sassa	NULL
S	NULL
,	NULL
Miura	NULL
Y	NULL
:	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
erythropoietin-dependent	NULL
subline	NULL
,	NULL
UT-7/Epo	NULL
,	NULL
derived	NULL
from	NULL
human	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
UT-7	NULL
.	NULL

Blood	NULL
82:456	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Chiba	NULL
S	NULL
,	NULL
Takaku	NULL
F	NULL
,	NULL
Tange	NULL
T	NULL
,	NULL
Shibuya	NULL
K	NULL
,	NULL
Misawa	NULL
C	NULL
,	NULL
Sasaki	NULL
K	NULL
,	NULL
Miyagawa	NULL
K	NULL
,	NULL
Yazaki	NULL
Y	NULL
,	NULL
Hirai	NULL
H	NULL
;	NULL
:	NULL
Establishment	NULL
and	NULL
erythroid	NULL
differentiation	NULL
of	NULL
a	NULL
cytokine-dependent	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
P-36	NULL
:	NULL
A	NULL
parental	NULL
line	NULL
requiring	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
or	NULL
interleukin-3	NULL
,	NULL
and	NULL
a	NULL
subline	NULL
requiring	NULL
erythropoietin	NULL
.	NULL

Blood	NULL
78:2261	NULL
,	NULL
1991	NULL
13	NULL
.	NULL

Kirito	NULL
K	NULL
,	NULL
Uchida	NULL
M	NULL
,	NULL
Yamada	NULL
M	NULL
,	NULL
Miura	NULL
Y	NULL
,	NULL
Komatsu	NULL
N	NULL
:	NULL
A	NULL
distinct	NULL
function	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
erythropoietin	NULL
signal	NULL
transduction	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:16507	NULL
,	NULL
1997	NULL
14	NULL
.	NULL

Komatsu	NULL
N	NULL
,	NULL
Kirito	NULL
K	NULL
,	NULL
Shimizu	NULL
R	NULL
,	NULL
Kunitama	NULL
M	NULL
,	NULL
Yamada	NULL
M	NULL
,	NULL
Uchida	NULL
M	NULL
,	NULL
Takatoku	NULL
M	NULL
,	NULL
Eguchi	NULL
M	NULL
,	NULL
Miura	NULL
Y	NULL
:	NULL
In	NULL
vitro	NULL
development	NULL
of	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
cells	NULL
from	NULL
a	NULL
UT-7	NULL
subline	NULL
,	NULL
UT-7/GM	NULL
.	NULL

Blood	NULL
89:4021	NULL
,	NULL
1997	NULL
15	NULL
.	NULL

Kitamura	NULL
T	NULL
,	NULL
Tange	NULL
T	NULL
,	NULL
Terasawa	NULL
T	NULL
,	NULL
Chiba	NULL
S	NULL
,	NULL
Kuwaki	NULL
T	NULL
,	NULL
Miyagawa	NULL
K	NULL
,	NULL
Piao	NULL
Y-F	NULL
,	NULL
Miyazono	NULL
K	NULL
,	NULL
Urabe	NULL
A	NULL
,	NULL
Takaku	NULL
F	NULL
:	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
unique	NULL
human	NULL
cell	NULL
line	NULL
that	NULL
proliferates	NULL
depen-dently	NULL
on	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
or	NULL
erythropoietin	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
140:323	NULL
,	NULL
1989	NULL
16	NULL
.	NULL

Nakajima	NULL
K	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Nakae	NULL
K	NULL
,	NULL
Kojima	NULL
H	NULL
,	NULL
Ichiba	NULL
M	NULL
,	NULL
Kiuchi	NULL
N	NULL
,	NULL
Kitaoka	NULL
T	NULL
,	NULL
Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
A	NULL
central	NULL
role	NULL
for	NULL
Stat3	NULL
in	NULL
IL-6-induced	NULL
regulation	NULL
of	NULL
growth	NULL
and	NULL
differentiation	NULL
in	NULL
M1	NULL
leukemia	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
15:3651	NULL
,	NULL
1996	NULL
17	NULL
.	NULL

Minami	NULL
M	NULL
,	NULL
Inoue	NULL
M	NULL
,	NULL
Wei	NULL
S	NULL
,	NULL
Takeda	NULL
K	NULL
,	NULL
Matsumoto	NULL
M	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Akira	NULL
S	NULL
:	NULL
STAT3	NULL
activation	NULL
is	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
gp130-mediated	NULL
terminal	NULL
differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
of	NULL
a	NULL
myeloid	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:3963	NULL
,	NULL
1996	NULL
18	NULL
.	NULL

Shimozaki	NULL
K	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
Involvement	NULL
of	NULL
STAT3	NULL
in	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor-induced	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:25184	NULL
,	NULL
1997	NULL
19	NULL
.	NULL

Chretien	NULL
S	NULL
,	NULL
Varlet	NULL
P	NULL
,	NULL
Verdier	NULL
F	NULL
,	NULL
Gobert	NULL
S	NULL
,	NULL
Carton	NULL
J-P	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Mayeux	NULL
P	NULL
,	NULL
Lacombe	NULL
C	NULL
:	NULL
Erythropoietin-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
TE-1	NULL
correlates	NULL
with	NULL
impaired	NULL
STATS	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
15:4174	NULL
,	NULL
1996	NULL
20	NULL
.	NULL

Iwatsuki	NULL
K	NULL
,	NULL
Endo	NULL
T	NULL
,	NULL
Misawa	NULL
H	NULL
,	NULL
Yokouchi	NULL
M	NULL
,	NULL
Matsumoto	NULL
A	NULL
,	NULL
Ohtsubo	NULL
M	NULL
,	NULL
Mori	NULL
KJ	NULL
,	NULL
Yoshimura	NULL
A	NULL
:	NULL
activation	NULL
correlates	NULL
with	NULL
erythropoietin	NULL
receptor	NULL
mediated	NULL
erythroid	NULL
differentiation	NULL
of	NULL
an	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:8149	NULL
,	NULL
1997	NULL
21	NULL
.	NULL

Guimaraes	NULL
JE	NULL
,	NULL
Berney	NULL
JJ	NULL
,	NULL
Francis	NULL
GE	NULL
,	NULL
Hoffbrand	NULL
AV	NULL
:	NULL
The	NULL
identification	NULL
of	NULL
mixed	NULL
granulocytic-erythrocytic	NULL
colonies	NULL
in	NULL
vitro	NULL
.	NULL

Exp	NULL
Hematol	NULL
12:535	NULL
,	NULL
1984	NULL
22	NULL
.	NULL

Wagner	NULL
BJ	NULL
,	NULL
Hayes	NULL
TE	NULL
,	NULL
Hoban	NULL
CJ	NULL
,	NULL
Cochran	NULL
BH	NULL
:	NULL
The	NULL
SIF	NULL
binding	NULL
element	NULL
confers	NULL
sis/PDGF	NULL
inducibility	NULL
onto	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
9:4477	NULL
,	NULL
1990	NULL
23	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Mammary	NULL
gland	NULL
factor	NULL
(	NULL
MGF	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
regulated	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
and	NULL
confers	NULL
the	NULL
prolactin	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
13:2182	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Kimura	NULL
M	NULL
,	NULL
Takatsuki	NULL
A	NULL
,	NULL
Yamaguchi	NULL
I	NULL
:	NULL
Balsticidin	NULL
S	NULL
deaminase	NULL
gene	NULL
from	NULL
Aspergillus	NULL
terreus	NULL
(	NULL
BSD	NULL
)	NULL
:	NULL
A	NULL
new	NULL
drug	NULL
resistance	NULL
gene	NULL
for	NULL
transfection	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Acta	NULL
1219:653	NULL
,	NULL
1994	NULL
25	NULL
.	NULL

Mosmann	NULL
T	NULL
:	NULL
Rapid	NULL
colorimetric	NULL
assay	NULL
for	NULL
cellular	NULL
growth	NULL
and	NULL
survival	NULL
:	NULL
Application	NULL
to	NULL
proliferation	NULL
and	NULL
cytotoxicity	NULL
assays	NULL
.	NULL

J	NULL
Immu-nol	NULL
Methods	NULL
65:55	NULL
,	NULL
1983	NULL
26	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
27	NULL
.	NULL

Carroll	NULL
M	NULL
,	NULL
Zhu	NULL
Y	NULL
,	NULL
D'Andrea	NULL
AD	NULL
:	NULL
Erythropoietin-induced	NULL
cellu-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

STAT	NULL
PROTEINS	NULL
AND	NULL
ERYTHROID	NULL
DIFFERENTIATION	NULL
lar	NULL
differentiation	NULL
requires	NULL
prolongation	NULL
of	NULL
the	NULL
G1	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:2869	NULL
,	NULL
1995	NULL
28	NULL
.	NULL

Kros	NULL
!	NULL

J	NULL
,	NULL
Damen	NULL
JE	NULL
,	NULL
Krystal	NULL
G	NULL
,	NULL
Humphries	NULL
RK	NULL
:	NULL
Erythropoietin	NULL
and	NULL
interleukin-3	NULL
induce	NULL
distinct	NULL
events	NULL
in	NULL
erythropoietin	NULL
receptor-expressing	NULL
BA/F3	NULL
cells	NULL
.	NULL

Blood	NULL
85:50	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

Thara	NULL
S	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Nagata	NULL
S	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Fukui	NULL
Y	NULL
:	NULL
Dual	NULL
control	NULL
of	NULL
neurite	NULL
outgrowth	NULL
by	NULL
STAT3	NULL
and	NULL
MAP	NULL
kinase	NULL
in	NULL
PC	NULL
12	NULL
cells	NULL
stimulated	NULL
with	NULL
interleukin-6	NULL
.	NULL

EMBO	NULL
J	NULL
16:5345	NULL
,	NULL
1997	NULL
30	NULL
.	NULL

Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Takahashi-Tezuka	NULL
M	NULL
,	NULL
Fujitani	NULL
Y	NULL
,	NULL
Yamaguchi	NULL
T	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Two	NULL
signals	NULL
are	NULL
necessary	NULL
for	NULL
cell	NULL
proliferation	NULL
induced	NULL
by	NULL
a	NULL
cytokine	NULL
receptor	NULL
gp130	NULL
:	NULL
Involvement	NULL
of	NULL
STAT3	NULL
in	NULL
anti-apoptosis	NULL
.	NULL

Immunity	NULL
5:449	NULL
,	NULL
1996	NULL
31	NULL
.	NULL

Marra	NULL
F	NULL
,	NULL
Choudhury	NULL
GG	NULL
,	NULL
Abboud	NULL
HE	NULL
:	NULL
Interferon-y-mediated	NULL
activation	NULL
of	NULL
Statle	NULL
regulates	NULL
growth	NULL
factor-induced	NULL
mitogenesis	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
98:1218	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

Chin	NULL
YE	NULL
,	NULL
Kitagawa	NULL
M	NULL
,	NULL
Su	NULL
W-CS	NULL
,	NULL
You	NULL
Z-H	NULL
,	NULL
Iwamoto	NULL
Y	NULL
,	NULL
Fu	NULL
X-Y	NULL
:	NULL
Cell	NULL
growth	NULL
arrest	NULL
and	NULL
induction	NULL
of	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitor	NULL
p21	NULL
WAE-1/CIP1	NULL
mediated	NULL
by	NULL
STAT1	NULL
.	NULL

Science	NULL
272:719	NULL
,	NULL
1996	NULL
33	NULL
.	NULL

Mantel	NULL
C	NULL
,	NULL
Luo	NULL
Z	NULL
,	NULL
Canfield	NULL
J	NULL
,	NULL
Braun	NULL
S	NULL
,	NULL
Broxmeyer	NULL
HE	NULL
:	NULL
Involvement	NULL
of	NULL
p21cip-1	NULL
and	NULL
p27kip-1	NULL
in	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
steel	NULL
factor-induced	NULL
proliferative	NULL
synergy	NULL
in	NULL
vitro	NULL
and	NULL
of	NULL
p21cip-1	NULL
in	NULL
the	NULL
maintenance	NULL
of	NULL
stem/progenitor	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Blood	NULL
88:3710	NULL
,	NULL
1996	NULL
34	NULL
.	NULL

LaBaer	NULL
J	NULL
,	NULL
Garrett	NULL
MD	NULL
,	NULL
Stevenson	NULL
LF	NULL
,	NULL
Slingerland	NULL
JM	NULL
,	NULL
Sandhu	NULL
C	NULL
,	NULL
Chou	NULL
HS	NULL
,	NULL
Fattaey	NULL
A	NULL
,	NULL
Harlow	NULL
E	NULL
:	NULL
New	NULL
functional	NULL
activities	NULL
for	NULL
the	NULL
p21	NULL
family	NULL
of	NULL
CDK	NULL
inhibitors	NULL
.	NULL

Genes	NULL
Dev	NULL
11:847	NULL
,	NULL
1997	NULL
35	NULL
.	NULL

Boeuf	NULL
H	NULL
,	NULL
Hauss	NULL
C	NULL
,	NULL
De	NULL
Graeve	NULL
F	NULL
,	NULL
Baran	NULL
N	NULL
,	NULL
Kedinger	NULL
C	NULL
:	NULL
Leukemia	NULL
inhibitory	NULL
factor-dependent	NULL
transcriptional	NULL
activation	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
138:1207	NULL
,	NULL
1997	NULL
36	NULL
.	NULL

Tillbrook	NULL
PA	NULL
,	NULL
Ingley	NULL
E	NULL
,	NULL
Williams	NULL
JH	NULL
,	NULL
Hibbs	NULL
ML	NULL
,	NULL
Klinken	NULL
SP	NULL
:	NULL
Lyn	NULL
tyrosine	NULL
kinase	NULL
is	NULL
essential	NULL
for	NULL
erythropoietin-induced	NULL
differentiation	NULL
of	NULL
J2E	NULL
erythroid	NULL
cells	NULL
.	NULL

EMBO	NULL
7:1610	NULL
,	NULL
1997	NULL
37	NULL
.	NULL

Sharlow	NULL
ER	NULL
,	NULL
Pacifici	NULL
R	NULL
,	NULL
Crouse	NULL
J	NULL
,	NULL
Batac	NULL
J	NULL
,	NULL
Todokoro	NULL
K	NULL
,	NULL
Wojchowski	NULL
DM	NULL
:	NULL
Hematopoietic	NULL
cell	NULL
phosphatase	NULL
negatively	NULL
regulates	NULL
erythropoietin-induced	NULL
hemoglobinization	NULL
in	NULL
erythroleukemic	NULL
SKT6	NULL
cells	NULL
.	NULL

Blood	NULL
90:2175	NULL
,	NULL
1997	NULL
38	NULL
.	NULL

Migone	NULL
T-S	NULL
,	NULL
Lin	NULL
J-X	NULL
,	NULL
Cereseto	NULL
A	NULL
,	NULL
Mulloy	NULL
JC	NULL
,	NULL
O'Shea	NULL
JJ	NULL
,	NULL
Franchini	NULL
G	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
Constitutively	NULL
activated	NULL
Jak-STAT	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
transformed	NULL
with	NULL
HTLV-1	NULL
.	NULL

Science	NULL
269:79	NULL
,	NULL
1995	NULL
39	NULL
.	NULL

Weber	NULL
NR	NULL
,	NULL
Egen	NULL
C	NULL
,	NULL
Wehinger	NULL
J	NULL
,	NULL
Ludwig	NULL
W	NULL
,	NULL
Gouilleux	NULL
GV	NULL
,	NULL
Mertelsmann	NULL
R	NULL
,	NULL
Finke	NULL
J	NULL
:	NULL
Constitutive	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
primary	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
and	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-related	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
88:809	NULL
,	NULL
1996	NULL
40	NULL
.	NULL

Gouilleux	NULL
GV	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Desaint	NULL
C	NULL
,	NULL
Claisse	NULL
JF	NULL
,	NULL
Capiod	NULL
JC	NULL
,	NULL
Delobel	NULL
J	NULL
,	NULL
Weber	NULL
NRM	NULL
,	NULL
Dusanter	NULL
FI	NULL
,	NULL
Dreyfus	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Prin	NULL
L	NULL
:	NULL
STAT-related	NULL
transcription	NULL
factors	NULL
are	NULL
constitutively	NULL
activated	NULL
in	NULL
peripheral	NULL
blood	NULL
cells	NULL
from	NULL
acute	NULL
leukemia	NULL
patients	NULL
.	NULL

Blood	NULL
87:1692	NULL
,	NULL
1996	NULL
41	NULL
.	NULL

Carlesso	NULL
N	NULL
,	NULL
Frank	NULL
DA	NULL
,	NULL
Griffin	NULL
JD	NULL
:	NULL
Tyrosyl	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
proteins	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
transformed	NULL
by	NULL
Ber/Abl	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
183:811	NULL
,	NULL
1996	NULL
42	NULL
.	NULL

Yu	NULL
CL	NULL
,	NULL
Meyer	NULL
DJ	NULL
,	NULL
Campbell	NULL
GS	NULL
,	NULL
Larner	NULL
AC	NULL
,	NULL
Carter	NULL
SC	NULL
,	NULL
Schwartz	NULL
J	NULL
,	NULL
Jove	NULL
R	NULL
:	NULL
Enhanced	NULL
DNA-binding	NULL
activity	NULL
of	NULL
a	NULL
Stat3-related	NULL
471	NULL
protein	NULL
in	NULL
cells	NULL
transformed	NULL
by	NULL
the	NULL
Sre	NULL
oncoprotein	NULL
.	NULL

Science	NULL
269:81	NULL
,	NULL
1995	NULL
43	NULL
.	NULL

Cao	NULL
X	NULL
,	NULL
Tay	NULL
A	NULL
,	NULL
Guy	NULL
GR	NULL
,	NULL
Tan	NULL
YH	NULL
:	NULL
Activation	NULL
and	NULL
association	NULL
of	NULL
Stat3	NULL
with	NULL
Src	NULL
in	NULL
v-Src-transformed	NULL
cell	NULL
lines	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:1595	NULL
,	NULL
1996	NULL
44	NULL
.	NULL

Ohashi	NULL
T	NULL
,	NULL
Masuda	NULL
M	NULL
,	NULL
Ruscetti	NULL
SK	NULL
:	NULL
Induction	NULL
of	NULL
sequence-specific	NULL
DNA-binding	NULL
factors	NULL
by	NULL
erythropoietin	NULL
and	NULL
the	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
.	NULL

Blood	NULL
85:1454	NULL
,	NULL
1995	NULL
45	NULL
.	NULL

Harrison	NULL
DA	NULL
,	NULL
Binari	NULL
R	NULL
,	NULL
Nahreini	NULL
TS	NULL
,	NULL
Gilman	NULL
M	NULL
,	NULL
Perrimon	NULL
N	NULL
:	NULL
Activation	NULL
of	NULL
a	NULL
Drosophila	NULL
Janus	NULL
kinase	NULL
(	NULL
JAK	NULL
)	NULL
causes	NULL
hematopoietic	NULL
neoplasia	NULL
and	NULL
developmental	NULL
defects	NULL
.	NULL

EMBO	NULL
J	NULL
14:2857	NULL
,	NULL
1995	NULL
46	NULL
.	NULL

Luo	NULL
H	NULL
,	NULL
Hanratty	NULL
WP	NULL
,	NULL
Dearolf	NULL
CR	NULL
:	NULL
An	NULL
amino	NULL
acid	NULL
substitution	NULL
in	NULL
the	NULL
Drosophila	NULL
hopTum-1	NULL
Jak	NULL
kinase	NULL
causes	NULL
leukemia-like	NULL
hematopoietic	NULL
defects	NULL
.	NULL

EMBO	NULL
J	NULL
14:1412	NULL
,	NULL
1995	NULL
47	NULL
.	NULL

Luo	NULL
H	NULL
,	NULL
Rose	NULL
P	NULL
,	NULL
Barber	NULL
D	NULL
,	NULL
Hanratty	NULL
WP	NULL
,	NULL
Lee	NULL
S	NULL
,	NULL
Roberts	NULL
TM	NULL
,	NULL
D'Andrea	NULL
AD	NULL
,	NULL
Dearolf	NULL
CR	NULL
:	NULL
Mutation	NULL
in	NULL
the	NULL
Jak	NULL
kinase	NULL
JH2	NULL
domain	NULL
hyperactivates	NULL
Drosophila	NULL
and	NULL
mammalian	NULL
Jak-Stat	NULL
pathways	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:1562	NULL
,	NULL
1997	NULL
48	NULL
.	NULL

Takeda	NULL
K	NULL
,	NULL
Noguchi	NULL
K	NULL
,	NULL
Shi	NULL
W	NULL
,	NULL
Tanaka	NULL
T	NULL
,	NULL
Matsumoto	NULL
M	NULL
,	NULL
Yoshida	NULL
N	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Akira	NULL
S	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
Stat3	NULL
gene	NULL
leads	NULL
to	NULL
early	NULL
embryonic	NULL
lethality	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:3801	NULL
,	NULL
1997	NULL
49	NULL
.	NULL

Durbin	NULL
JE	NULL
,	NULL
Hackenmiller	NULL
R	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Levy	NULL
DE	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
Statl	NULL
gene	NULL
results	NULL
in	NULL
compromised	NULL
innate	NULL
immunity	NULL
to	NULL
viral	NULL
disease	NULL
.	NULL

Cell	NULL
84:443	NULL
,	NULL
1996	NULL
50	NULL
.	NULL

Meraz	NULL
MA	NULL
,	NULL
White	NULL
JM	NULL
,	NULL
Sheehan	NULL
KC	NULL
,	NULL
Bach	NULL
EA	NULL
,	NULL
Rodig	NULL
SJ	NULL
,	NULL
Dighe	NULL
AS	NULL
,	NULL
Kaplan	NULL
DH	NULL
,	NULL
Riley	NULL
JK	NULL
,	NULL
Greenlund	NULL
AC	NULL
,	NULL
Campbell	NULL
D	NULL
,	NULL
Carver-Moore	NULL
K	NULL
,	NULL
DuBois	NULL
RN	NULL
,	NULL
Clark	NULL
R	NULL
,	NULL
Aguet	NULL
M	NULL
,	NULL
Schreiber	NULL
RD	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
Statl	NULL
gene	NULL
in	NULL
mice	NULL
reveals	NULL
unexpected	NULL
physiologic	NULL
specificity	NULL
in	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
84:431	NULL
,	NULL
1996	NULL
51	NULL
.	NULL

Nakamura	NULL
Y	NULL
,	NULL
Komatsu	NULL
N	NULL
,	NULL
Nakauchi	NULL
H	NULL
:	NULL
A	NULL
truncated	NULL
erythropoietin	NULL
receptor	NULL
that	NULL
fails	NULL
to	NULL
prevent	NULL
programmed	NULL
cell	NULL
death	NULL
of	NULL
erythroid	NULL
cells	NULL
.	NULL

Science	NULL
257:1138	NULL
,	NULL
1992	NULL
52	NULL
.	NULL

Chretien	NULL
S	NULL
,	NULL
Moreau-Gachelin	NULL
F	NULL
,	NULL
Apiou	NULL
F	NULL
,	NULL
Courtois	NULL
G	NULL
,	NULL
Mayeux	NULL
P	NULL
,	NULL
Dutrillaux	NULL
B	NULL
,	NULL
Carton	NULL
JP	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Lacombe	NULL
C	NULL
:	NULL
Putative	NULL
oncogenic	NULL
role	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
in	NULL
murine	NULL
and	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Blood	NULL
83:1813	NULL
,	NULL
1994	NULL
53	NULL
.	NULL

Pallard	NULL
C	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Charon	NULL
M	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Dusanter-Fourt	NULL
I	NULL
:	NULL
Interleukin-3	NULL
,	NULL
erythropoietin	NULL
,	NULL
and	NULL
prolactin	NULL
activate	NULL
a	NULL
STATS5-like	NULL
factor	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:15942	NULL
,	NULL
1995	NULL
54	NULL
.	NULL

Klingmuller	NULL
U	NULL
,	NULL
Bergelson	NULL
S	NULL
,	NULL
Hsiao	NULL
JG	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Multiple	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
promote	NULL
activation	NULL
of	NULL
STATS	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:8324	NULL
,	NULL
1996	NULL
55	NULL
.	NULL

Reese	NULL
TT	NULL
,	NULL
Gregory	NULL
RC	NULL
,	NULL
Sharlow	NULL
ER	NULL
,	NULL
Pacifici	NULL
RE	NULL
,	NULL
Crouse	NULL
JA	NULL
,	NULL
Todokoro	NULL
K	NULL
,	NULL
Wojchowski	NULL
DM	NULL
:	NULL
Epo-induced	NULL
hemoglobinization	NULL
of	NULL
SKT6	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
minimal	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
the	NULL
Epo	NULL
or	NULL
prolactin	NULL
receptors	NULL
without	NULL
modulation	NULL
of	NULL
GATA-1	NULL
or	NULL
EKLF	NULL
.	NULL

Growth	NULL
Factors	NULL
14:161	NULL
,	NULL
1997	NULL
56	NULL
.	NULL

Penta	NULL
K	NULL
,	NULL
Sawyer	NULL
ST	NULL
:	NULL
Erythropoietin	NULL
induces	NULL
the	NULL
tyrosine	NULL
phos-phorylation	NULL
,	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
STAT1	NULL
and	NULL
STATS	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:31282	NULL
,	NULL
1995	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
~*	NULL
A	NULL
Novel	NULL
Function	NULL
of	NULL
Static	NULL
and	NULL
Stat3	NULL
Proteins	NULL
in	NULL
Erythropoietin-Induced	NULL
Erythroid	NULL
Differentiation	NULL
of	NULL
a	NULL
Human	NULL
Leukemia	NULL
Cell	NULL
Line	NULL
Keita	NULL
Kirito	NULL
,	NULL
Mie	NULL
Uchida	NULL
,	NULL
Masaaki	NULL
Takatoku	NULL
,	NULL
Koichi	NULL
Nakajima	NULL
,	NULL
Toshio	NULL
Hirano	NULL
,	NULL
Yasusada	NULL
Miura	NULL
and	NULL
Norio	NULL
Komatsu	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtow®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/2/462.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

